
<html lang="en"     class="pb-page"  data-request-id="29881500-f808-448f-a2a3-06c3975ae6ea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm5019274;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-4"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents" /></meta><meta name="dc.Creator" content="Jianjun  Cheng" /></meta><meta name="dc.Creator" content="Patrick M.  Giguère" /></meta><meta name="dc.Creator" content="Oluseye K.  Onajole" /></meta><meta name="dc.Creator" content="Wei  Lv" /></meta><meta name="dc.Creator" content="Arsen  Gaisin" /></meta><meta name="dc.Creator" content="Hendra  Gunosewoyo" /></meta><meta name="dc.Creator" content="Claire M.  Schmerberg" /></meta><meta name="dc.Creator" content="Vladimir M.  Pogorelov" /></meta><meta name="dc.Creator" content="Ramona M.  Rodriguiz" /></meta><meta name="dc.Creator" content="Giulio  Vistoli" /></meta><meta name="dc.Creator" content="William C.  Wetsel" /></meta><meta name="dc.Creator" content="Bryan L.  Roth" /></meta><meta name="dc.Creator" content="Alan P.  Kozikowski" /></meta><meta name="dc.Description" content="The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold..." /></meta><meta name="Description" content="The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 10, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5019274" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5019274" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5019274" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5019274" /></link>
        
    
    

<title>Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5019274" /></meta><meta property="og:title" content="Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0009.jpeg" /></meta><meta property="og:description" content="The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold. Modifications focused on the alkoxyl substituent present on the aromatic ring led to the identification of improved ligands with better potency at the 5-HT2C receptor and excellent selectivity against the 5-HT2A and 5-HT2B receptors. ADMET studies coupled with a behavioral test using the amphetamine-induced hyperactivity model identified four compounds possessing drug-like profiles and having antipsychotic properties. Compound (+)-16b, which displayed an EC50 of 4.2 nM at 5-HT2C, no activity at 5-HT2B, and an 89-fold selectivity against 5-HT2A, is one of the most potent and selective 5-HT2C agonists reported to date. The likely binding mode of this series of compounds to the 5-HT2C receptor was also investigated in a modeling study, using optimized models incorporating the structures of β2-adrenergic receptor and 5-HT2B receptor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5019274"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5019274">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5019274&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5019274&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5019274&amp;href=/doi/10.1021/jm5019274" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1992-2002</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501921k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501945w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianjun++Cheng">Jianjun Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+M.++Gigu%C3%A8re">Patrick M. Giguère</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oluseye+K.++Onajole">Oluseye K. Onajole</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Lv">Wei Lv</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arsen++Gaisin">Arsen Gaisin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hendra++Gunosewoyo">Hendra Gunosewoyo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire+M.++Schmerberg">Claire M. Schmerberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir+M.++Pogorelov">Vladimir M. Pogorelov</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramona+M.++Rodriguiz">Ramona M. Rodriguiz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giulio++Vistoli">Giulio Vistoli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+C.++Wetsel">William C. Wetsel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+L.++Roth">Bryan L. Roth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+P.++Kozikowski">Alan P. Kozikowski</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, North Carolina 27599, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Psychiatry and Behavioral Sciences, Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milano, Italy</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1 312 996-7577. E-mail: <a href="/cdn-cgi/l/email-protection#4d2622372426223a2c0d38242e63282938"><span class="__cf_email__" data-cfemail="c1aaaebba8aaaeb6a081b4a8a2efa4a5b4">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5019274&amp;href=/doi/10.1021%2Fjm5019274" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1992–2002</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 29, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 December 2014</li><li><span class="item_label"><b>Published</b> online</span>10 February 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 February 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5019274" title="DOI URL">https://doi.org/10.1021/jm5019274</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1992%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJianjun%2BCheng%252C%2BPatrick%2BM.%2BGigu%25C3%25A8re%252C%2BOluseye%2BK.%2BOnajole%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D4%26contentID%3Djm5019274%26title%3DOptimization%2Bof%2B2-Phenylcyclopropylmethylamines%2Bas%2BSelective%2BSerotonin%2B2C%2BReceptor%2BAgonists%2Band%2BTheir%2BEvaluation%2Bas%2BPotential%2BAntipsychotic%2BAgents%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2002%26publicationDate%3DFebruary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5019274"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1280</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5019274" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jianjun&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;M. Giguère&quot;},{&quot;first_name&quot;:&quot;Oluseye&quot;,&quot;last_name&quot;:&quot;K. Onajole&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Lv&quot;},{&quot;first_name&quot;:&quot;Arsen&quot;,&quot;last_name&quot;:&quot;Gaisin&quot;},{&quot;first_name&quot;:&quot;Hendra&quot;,&quot;last_name&quot;:&quot;Gunosewoyo&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;M. Schmerberg&quot;},{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;M. Pogorelov&quot;},{&quot;first_name&quot;:&quot;Ramona&quot;,&quot;last_name&quot;:&quot;M. Rodriguiz&quot;},{&quot;first_name&quot;:&quot;Giulio&quot;,&quot;last_name&quot;:&quot;Vistoli&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;C. Wetsel&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;L. Roth&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;P. Kozikowski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;1992-2002&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5019274&quot;},&quot;abstract&quot;:&quot;The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold. Modifications focused on the alkoxyl substituent present on the aromatic ring led to the identification of improved ligands with better potency at the 5-HT2C receptor and excellent selectivity against the 5-HT2A and 5-HT2B receptors. ADMET studies coupled with a behavioral test using the amphetamine-induced hyperactivity model identified four compounds possessing drug-like profiles and having antipsychotic properties. Compound (+)-16b, which displayed an EC50 of 4.2 nM at 5-HT2C, no activity at 5-HT2B, and an 89-fold selectivity against 5-HT2A, is one of the most potent and selective 5-HT2C agonists reported to date. The likely binding mode of this series of compounds to the 5-HT2C receptor was also investigated in a modeling study, using optimized models incorporating the structures of β2-adrenergic receptor and &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5019274&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019274" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5019274&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019274" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5019274&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019274" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5019274&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019274&amp;href=/doi/10.1021/jm5019274" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5019274" /></input><a href="/doi/pdf/10.1021/jm5019274" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5019274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5019274%26sid%3Dliteratum%253Aachs%26pmid%3D25633969%26genre%3Darticle%26aulast%3DCheng%26date%3D2015%26atitle%3DOptimization%2Bof%2B2-Phenylcyclopropylmethylamines%2Bas%2BSelective%2BSerotonin%2B2C%2BReceptor%2BAgonists%2Band%2BTheir%2BEvaluation%2Bas%2BPotential%2BAntipsychotic%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D4%26spage%3D1992%26epage%3D2002%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291285" title="Ethers">Ethers</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jmcmar.2015.58.issue-4/20150226/jmcmar.2015.58.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of a new series of compounds that are potent, selective 5-HT<sub>2C</sub> receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold. Modifications focused on the alkoxyl substituent present on the aromatic ring led to the identification of improved ligands with better potency at the 5-HT<sub>2C</sub> receptor and excellent selectivity against the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors. ADMET studies coupled with a behavioral test using the amphetamine-induced hyperactivity model identified four compounds possessing drug-like profiles and having antipsychotic properties. Compound (+)-<b>16b</b>, which displayed an EC<sub>50</sub> of 4.2 nM at 5-HT<sub>2C</sub>, no activity at 5-HT<sub>2B</sub>, and an 89-fold selectivity against 5-HT<sub>2A</sub>, is one of the most potent and selective 5-HT<sub>2C</sub> agonists reported to date. The likely binding mode of this series of compounds to the 5-HT<sub>2C</sub> receptor was also investigated in a modeling study, using optimized models incorporating the structures of β<sub>2</sub>-adrenergic receptor and 5-HT<sub>2B</sub> receptor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Serotonin or 5-hydroxytryptamine (5-HT) is a major neurotransmitter that is primarily found in the gastrointestinal tract, platelets, and the central nervous system (CNS). It is believed to be involved in the regulation of a variety of physiological functions such as intestinal movements, mood, cognition, and appetite.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These functions are mediated through serotonin receptors, which belong to the G-protein coupled receptor (GPCR) superfamily and are composed of seven subfamilies (5-HT<sub>1–7</sub>) and 14 isoforms.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Recently, the serotonin 2C (5-HT<sub>2C</sub>) receptor has been shown to be a promising drug target for the treatment of a variety of CNS disorders, including obesity and mental disorders such as schizophrenia, depression, and anxiety.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3-7)</a> One of the many advantages of the 5-HT<sub>2C</sub> receptor as a CNS drug target stems from the fact that it is found almost exclusively in the CNS,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> and thus compounds that selectively activate this receptor should have limited impact on peripheral tissues. However, the activation of two other closely related 5-HT<sub>2</sub> subtypes, namely the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors, has been reported to be associated with hallucinations and cardiac valvulopathy, respectively.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Therefore, the identification of ligands possessing exquisite selectivity against the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors is a key criterion for the therapeutic advancement of 5-HT<sub>2C</sub> agonists. The achievement of this goal has been challenging due to the high conservation of molecular determinants involved in ligand recognition within this subfamily of receptors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Currently, there are a number of 5-HT<sub>2C</sub> agonists (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1</b>–<b>6</b>) generated for potential therapeutic uses or as chemical tools for the study of the biological roles of 5-HT<sub>2C</sub> receptor. Among them, lorcaserin (Belviq, <b>1</b>) was approved by the FDA in 2012 for the treatment of obesity. Although it was reported to have 100-fold selectivity for 5-HT<sub>2C</sub> relative to the 5-HT<sub>2B</sub> subtype, lorcaserin possesses full agonist activity at 5-HT<sub>2B</sub> (EC<sub>50</sub> = 943 ± 90 nM, <i>E</i><sub>max</sub> = 100%).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Hence, it is not surprising that lorcaserin was found to cause a higher incidence of cardiac valve disorders in clinical trials compared to the placebo group.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative 5-HT<sub>2C</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Vabicaserin (SCA-136, <b>2</b>), by targeting 5-HT<sub>2C</sub> receptors (EC<sub>50</sub> = 8 nM, <i>E</i><sub>max</sub> = 100%), was tested in clinical trials for the treatment of schizophrenia;<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> however, it displayed moderate efficacy on 5-HT<sub>2B</sub> receptors (<i>E</i><sub>max</sub> = 50%) and good potency (EC<sub>50</sub> = 12 or 102 nM depending on receptor densities).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> WAY-163909 (<b>3</b>), an analogue of vabicaserin, was shown to have selectivity toward 5-HT<sub>2C</sub> (EC<sub>50</sub> = 8 nM; <i>E</i><sub>max</sub> = 90%) while possessing no agonist activity at 5-HT<sub>2A</sub> and weak efficacy at 5-HT<sub>2B</sub> receptors (<i>E</i><sub>max</sub> = 40%); it has proven to have good preclinical antipsychotic-like activity in several animal models.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound CP-809,101 (<b>4</b>) is one of the most selective and potent 5-HT<sub>2C</sub> (EC<sub>50</sub> = 0.11 nM, <i>E</i><sub>max</sub> = 93%) ligands developed, with about 600-fold 5-HT<sub>2C</sub> selectivity against 5-HT<sub>2B</sub>. However, it is still relatively potent at 5-HT<sub>2B</sub> (EC<sub>50</sub> = 65.3 nM, <i>E</i><sub>max</sub> = 57%).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Because of the genotoxicity of this compound, it could not be advanced to clinical evaluation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Nonetheless, CP-809,101 has structural similarities to <i>m</i>CPP (<b>5</b>) and MK-212 (<b>6</b>), two compounds discovered decades ago and used as tools for the pharmacological study of 5-HT<sub>2C</sub> receptors.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a></div><div class="NLM_p">In our own research, we focused on compounds that possessed the 2-phenylcyclopropylmethylamine scaffold (<b>7</b>) to develop selective 5-HT<sub>2C</sub> agonists. This particular scaffold was derived from an initial high throughput screening (HTS) screening campaign in which tranylcypromine was identified as a hit as described in an earlier publication.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Rational drug design principles coupled with the evolution of a body of structure–activity relationships (SARs) led to the identification of compounds possessing a 2-cyclopropylmethoxy group at position 2, as illustrated by compounds <b>8</b>, <b>9</b>, and <b>10</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Compound <b>8</b>, which possesses a fluorine substitution at position 5 of the benzene ring, showed good potency on the 5-HT<sub>2C</sub> receptor (EC<sub>50</sub> = 21 nM), with only moderate selectivity for 5-HT<sub>2B</sub> (EC<sub>50</sub> = 289 nM).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The replacement of the fluorine atom with a hydroxyl group, as in compound <b>9</b>, led to the enhancement of both potency and selectivity, but the bioavailability of compound <b>9</b> was found to be too low in a later study (<i>F</i> = 3.2% in mice, unpublished data). Compound <b>10</b>, with no substitution at the same position, showed good potency as a partial agonist (EC<sub>50</sub> = 55 nM, <i>E</i><sub>max</sub> = 61%), with great selectivity against both 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Considering the needs of more selective and potent 5-HT<sub>2C</sub> agonists for the validation of their therapeutic potential in the treatment of various illnesses associated with 5-HT<sub>2C</sub>, we conducted a new round of lead optimization on this promising scaffold. The chemical synthesis and SAR results obtained for the new compounds are reported herein, together with a rodent behavioral test and a homology modeling study. These new analogues provide improvements compared to previous compounds.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selective 5-HT<sub>2C</sub> agonists based on 2-phenylcyclopropylmethylamine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of 5-Chlorine Substituted Compounds</h3><div class="NLM_p">Prior SAR studies showed that compounds with an alkoxyl group at position 2 provided the most favorable 5-HT<sub>2C</sub> agonism and selectivity toward 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>, and thus this substitution pattern was therefore retained in further rounds of structural modifications. Through a careful structural analysis of known 5-HT<sub>2C</sub> agonists as well as other CNS drugs, it is apparent that a chlorine atom represents one of the most frequently used substituents for aromatic rings. This observation is exemplified by <i>m</i>CPP, MK-212, and lorcaserin, all of which contain a chlorine substituent located at a position <i>meta</i> to the nitrogen-containing group. Thus, we introduced the chlorine atom as the substituent at position 5, and further optimization of the alkyl ether group was conducted to improve 5-HT<sub>2C</sub> potency as well as selectivity over both 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>.</div><div class="NLM_p">As depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, the synthesis of the 5-chlorine containing analogues started from the corresponding phenol <b>11</b>, which was prepared using methods similar to those reported previously by us for the 5-bromo analogue.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The cyclopropane ring of <b>11</b> was prepared in its <i>trans</i> configuration, as this stereochemistry has proven to be favored in our previous SAR studies. The ether derivatives <b>12a</b>–<b>12n</b> were prepared either by a standard Williamson ether synthesis with an alkyl halide or by use of the Mitsunobu reaction with the appropriate alcohol (for details of the synthesis of <b>12a</b>–<b>12n</b>, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S1">Supporting Information, Table S1</a>). Chiral separations of <b>12a</b>–<b>12n</b> were achieved with preparative chiral HPLC and the corresponding (+)- and (−)-enantiomers were then subjected to Boc deprotection reactions to provide both (−)- and (+)- enantiomers of compounds <b>13a</b>–<b>13n</b> as their HCl or TFA salts. The absolute configurations of the enantiomers were assigned from the measured optical rotations coupled with the stereochemical correlations reported previously by us.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 5-Chloro Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Williamson ether synthesis with R<sup>1</sup>X or Mitsunobu reaction with appropriate alcohols; (b) chiral prep-HPLC separation; (c) <b>13c</b>, <b>13d</b>, <b>13f</b>, <b>13h</b>, and <b>13i</b>, TFA/CH<sub>2</sub>Cl<sub>2</sub>, rt, 1h; <b>13a</b>, <b>13b</b>, <b>13e</b>, <b>13g</b>, <b>13j</b>–<b>13n</b>, 2 M HCl in diethyl ether, rt, 24–48 h.</p></p></figure><div class="NLM_p">On the basis of the SAR data from our previous work, we hypothesized that the alkoxyl substituents at position 2 on the benzene ring might be accommodated within a hydrophobic cavity, which could vary in size among the 5-HT<sub>2C</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>2B</sub> receptors. This cavity might be slightly larger for the 5-HT<sub>2C</sub> receptors compared to the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors based on the observation that (1) small groups attached to position 2 displayed good activity at all three subtypes (less selectivity) and (2) increasing the size of the substituent resulted in a decrease in activity at 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> while retaining good activity at 5-HT<sub>2C</sub>. Accordingly, we believed that by achieving a proper balance of size and lipophilicity, we should be able to identify more potent 5-HT<sub>2C</sub> agonists with improved selectivity against the 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> subtypes.</div><div class="NLM_p">To explore this assumption, compounds with varied alkoxyl groups were designed and synthesized. Functional activities at the 5-HT<sub>2C</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>2B</sub> receptors were determined, and physiochemical properties related to possible CNS penetration such as the CLogP and LogBB values were calculated using the ACD Percepta program. These values are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Generally, the (+)-isomers of all new compounds were found to be more potent than the (−)-isomers, which is consistent with our previously published SAR data.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> As evidenced by compounds <b>13a</b>, <b>13b</b>, and <b>13c</b>, potency at the 5-HT<sub>2C</sub> receptor decreases with elongation of the alkyl chain, while selectivity over 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub> improves. <i>n</i>-Propyl substitution as in compound (+)-<b>13b</b> was favored with respect to both activity and selectivity. The change from an <i>n</i>-propyl group to an isopropyl group gave compound (+)-<b>13d</b> that has similar 5-HT<sub>2C</sub> activity but decreased selectivity against 5-HT<sub>2B</sub> (33-fold selectivity for (+)-<b>13b</b> vs 11-fold selectivity for (+)-<b>13d</b>). The cyclopropylmethoxy group was the preferred ether substituent at position 2 of the benzene ring based on our previous findings;<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> however, the use of this group as found in compound (+)-<b>13e</b> afforded only a moderate potency at 5-HT<sub>2C</sub> receptors (EC<sub>50</sub> = 251 nM, <i>E</i><sub>max</sub> = 75%). Incorporation of an additional heteroatom such as oxygen or sulfur into the ether appendage, as exemplified by compounds <b>13f</b> and <b>13g</b>, led to a large reduction in 5-HT<sub>2C</sub> activity as well as a predicted decrease in blood–brain barrier (BBB) penetration based upon the calculated LogBB values.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. 5-HT<sub>2C</sub> Activity and Selectivity Profiles of Compounds <b>13a</b>–<b>13n</b> and Their Predicted Physiochemical Properties<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0007.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Functional data were acquired with recombinant, stably expressed human serotonin receptors in the HEK-293 cell line, using a fluorescence imaging plate reader (FLIPR) assay; “NA”, no activity at 10 μM.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">CLogP and LogBB values were calculated for the free bases using the ACD Percepta program.</p></div></div><div></div></div><div class="NLM_p">Unsaturated alkyl groups, such as allyl and propargyl, were preferred both for their potency and selectivity, as revealed by compounds (+)-<b>13h</b> and (+)-<b>13i</b>. (+)-<b>13h</b> showed a moderately good pharmacological profile, with 60 nM potency at 5-HT<sub>2C</sub>, 37-fold selectivity against 5-HT<sub>2B</sub> (2211 nM), and no activity at 5-HT<sub>2A</sub>. Furthermore, good physiochemical properties were predicted for this compound. Similar potency and selectivity was observed for (+)-<b>13i</b> as well, however, it was predicted to have low brain penetration, as indicated by its LogBB value of −0.43. Allyl ethers bearing small modifications were also explored, as exemplified by compounds <b>13j</b> and <b>13k</b>. The presence of a fluorine substituent as in compound (+)-<b>13j</b> resulted in a 2-fold reduction in 5-HT<sub>2C</sub> activity compared to (+)-<b>13h</b> (133 vs 60 nM) while maintaining the same general selectivity profile against 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub>. The presence of the fluorine atom might provide some advantage in terms of pharmacokinetics due to the possibility of reducing oxidative metabolism of the double bond. By adding an additional methyl group to the position 2 of the allyl appendage as in compound (+)-<b>13k</b>, the potency was reduced to 212 nM at the 5-HT<sub>2C</sub> receptors while its selectivity also decreased in comparison to compounds <b>13h</b> and <b>13j</b>.</div><div class="NLM_p">The 2-fluoroethyl ether analogue (+)-<b>13l</b> displayed 32 nM potency at 5-HT<sub>2C</sub> and good selectivity against both 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>. Upon introducing one additional fluorine atom into the molecule by way of a 2,2-difluoroethyl appendage as in analogue <b>13m</b>, a 3-fold decrease in activity at 5-HT<sub>2C</sub> (EC<sub>50</sub> = 91 nM vs 32 nM) was observed. This drop in activity may result from either increased steric hindrance or electronic effects. Additionally, the incorporation of a 3-fluoropropyl ether appendage as in (+)-<b>13n</b> also led to a drop in potency (EC<sub>50</sub> = 206 nM) compared to the simple unsubstituted propyl derivative (+)-<b>13b</b>, although (+)-<b>13n</b> possessed a reasonably good selectivity profile.</div><div class="NLM_p last">On the basis of the data from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compounds (+)-<b>13h</b> and (+)-<b>13l</b> represent the best ligands among this series of compounds, but they are about 10-fold less potent than lorcaserin, which shows an EC<sub>50</sub> value of 3.6 nM on 5-HT<sub>2C</sub> in the functional calcium-based assay. Although lorcaserin displays around 100-fold selectivity over both 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub>, it acts as a full or partial agonist at both receptors. As such, lorcaserin has potential side effect issues as discussed previously. Compounds (+)-<b>13h</b> and (+)-<b>13l</b>, along with (+)-<b>13j</b>, which might provide better PK properties due to the presence of the fluorine substitution, were advanced to in vitro ADMET studies.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> ADMET Studies</h3><div class="NLM_p">Compounds (+)-<b>13h</b>, (+)-<b>13j</b>, and (+)-<b>13l</b> were evaluated for selected in vitro ADME properties and toxicity profiles (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In Caco-2 permeability studies, compounds (+)-<b>13h</b>, (+)-<b>13j</b>, and (+)-<b>13l</b> displayed greater than 35 × 10<sup>–6</sup> cm/s A–B permeability in pH 7.4 buffer solution, and A–B/B–A ratios of 3.6, 3.5, and 2.0, respectively. When incubated with human and CD-1 mouse liver microsomes, all three compounds retained reasonably good stability, with more than 50% compound remaining after 1 h. Interestingly, although compound (+)-<b>13h</b> and (+)-<b>13j</b> displayed similar stability in the mouse liver microsomes test (60% vs 62%), (+)-<b>13j</b> had much better stability in the human microsomes study compared to (+)-<b>13h</b> (80% vs 52%), which could be due to the presence of the fluorine substitution as expected. Relatively low human plasma protein binding (57–75%) was measured for compounds (+)-<b>13h</b>, (+)-<b>13j</b>, and (+)-<b>13l</b>, which was expected based on their good CLogP values (between 2 and 3 as in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), as Log <i>P</i> is an important indicator that determines protein binding properties.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro ADMET Data for Compounds (+)-<b>13h</b>, (+)-<b>13j</b>, and (+)-<b>13l</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">(+)-<b>13h</b></th><th class="colsep0 rowsep0" align="center">(+)-<b>13j</b></th><th class="colsep0 rowsep0" align="center">(+)-<b>13l</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 permeability (pH7.4, × 10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="left">A–B</td><td class="colsep0 rowsep0" align="left">35.6</td><td class="colsep0 rowsep0" align="left">38.3</td><td class="colsep0 rowsep0" align="left">35.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">B–A</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">17.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">microsomal stability (%)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human PPB at 10 μM (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition at 10 μM (%)</td><td class="colsep0 rowsep0" align="left">3A</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2B6</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">3.98</td><td class="colsep0 rowsep0" align="left">2.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ames fluctuation test</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">negative</td><td class="colsep0 rowsep0" align="left">negative</td><td class="colsep0 rowsep0" align="left">negative</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">This study was conducted at Cerep, Inc. (Redmond, USA); microsomal stability is presented as % compound remaining after 1 h incubation with human/mouse liver microsomes; the CYP inhibition assays were performed using human liver microsomes; midazolam, dextromethorphan, diclofenac, omeprazole, and bupropion were used as test substrates for the 3A, 2D6, 2C9, 2C19, and 2B6 isoforms, respectively; hERG inhibition was tested on CHO cells using the automated patch-clamp method; the Ames fluctuation test was performed with the TA98, TA100, TA1535, and TA1537 strains, with/without S9, at concentrations of 10, 50, and 100 μM.</p></div></div></div><div class="NLM_p">Human cytochrome P450 (CYP) enzyme inhibition studies were conducted using the five most important isoforms, 3A, 2D6, 2C9, 2C19, and 2B6, at compound concentrations of 10 μM. Similar profiles were observed for all three compounds, with low inhibition of CYP3A and CYP2C19 and relatively higher inhibition of the other three isoforms (>50%). Compound (+)-<b>13j</b> shows a slightly better profile compared to (+)-<b>13h</b>, which indicates another benefit of the fluorine substituent. In the hERG inhibition test with the automated patch-clamp assay, moderate inhibition was observed with compounds (+)-<b>13j</b> and (+)-<b>13l</b>, while (+)-<b>13h</b> was found to have an IC<sub>50</sub> of 0.27 μM. The Ames test was also conducted to preclude any mutagenic potential of these compounds; all three compounds showed negative results. Because of the high hERG activity of (+)-<b>13h</b>, this compound was not further evaluated. Thus, only compounds (+)-<b>13j</b> and (+)-<b>13l</b> were submitted to the in vivo brain penetration studies.</div><div class="NLM_p">Brain penetration studies of (+)-<b>13j</b> and (+)-<b>13l</b> were conducted with CD1 mice, and the results are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Excellent brain penetration was observed for both compounds, with brain concentrations of greater than 50 μM achieved at a dose of 10 mg/kg (ip) and with brain/plasma ratios over 10 at both time-points (0.5 and 2 h). The excellent brain penetration for these two compounds coupled with low plasma protein binding should ensure optimal CNS distribution of both compounds. The lower plasma concentrations would also help to mitigate possible cardiac toxicity related to hERG inhibition observed in the previous ADMET studies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Brain Penetration Study of Compounds (+)-<b>13j</b> and (+)-<b>13l</b> in CD1 Mice<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">time-point (h)</th><th class="colsep0 rowsep0" align="center" char=".">brain concentration (ng/g)</th><th class="colsep0 rowsep0" align="center" char=".">plasma concentration (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">ratio (brain/plasma)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(+)-<b>13j</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">17460</td><td class="colsep0 rowsep0" align="char" char=".">1445</td><td class="colsep0 rowsep0" align="char" char=".">12.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">14670</td><td class="colsep0 rowsep0" align="char" char=".">903</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(+)-<b>13l</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">12795</td><td class="colsep0 rowsep0" align="char" char=".">1200</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">13350</td><td class="colsep0 rowsep0" align="char" char=".">874</td><td class="colsep0 rowsep0" align="char" char=".">15.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">CD1 mice were administrated a single dose of both compounds (10 mg/kg, ip, formulation in pure water).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Density of mouse brain tissue was calculated as 1 g/mL.</p></div></div></div><div class="NLM_p">While both compounds (+)-<b>13j</b> and (+)-<b>13l</b> showed good pharmacological profiles, acceptable ADMET properties, and excellent brain penetration, their moderate hERG inhibition could be a concern for further development. A similarity analysis of their structures with known hERG inhibitors revealed that the scaffold embodied by this series of compounds matched one of the common structural templates known to cause hERG inhibition, which is comprised of a three-point pharmacophore containing an aromatic ring, an adjacent hydrogen-bond donor, and an ionizable N atom.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> However, the 5-fluoro containing compound <b>8</b> displayed no hERG inhibition in our previous studies.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Thus, replacement of the chlorine atom by the less lipophilic fluorine atom at position 5 might lead to a decrease in hERG inhibition. Moreover, from the SAR data gleaned from the study of the 5-chloro bearing compounds, we concluded that some of the alkoxyl substitutions at position 2 on the benzene ring may provide advantages over the cyclopropylmethoxy group found in compounds <b>13e</b> and <b>8</b> in terms of potency and selectivity. Therefore, the introduction of these substituents into the 5-fluoro containing scaffold might produce compounds with better potency and, more importantly, reduced hERG inhibitory activity. Four different substituents from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were chosen for this purpose, and the synthesis and evaluation of these compounds are described below.</div><div class="NLM_p">Routes to the 5-fluoro compounds are depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. 5-Fluorophenol <b>14</b> was prepared and used as the starting material, the synthesis of which has been reported previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Alkylation of <b>14</b> with 1-iodopropane, allyl bromide, or 3-chloro-2-fluoropropene and a Mitsunobu reaction with 2-fluoroethanol provided the corresponding ethers <b>15a</b>–<b>15d</b> in excellent yields (for details of the synthesis of <b>15a</b>–<b>15d</b>, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S2">Supporting Information, Table S2</a>). These intermediates were separated using chiral preparative HPLC and then deprotected with HCl in diethyl ether to give both (−)- and (+)-enantiomers of compound <b>16a</b>–<b>16d</b>. Similarly, absolute configurations of the enantiomers were assigned based on the measured optical rotations as described above.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5-Fluoro Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Williamson ether synthesis with R<sup>1</sup>X or Mitsunobu reaction with appropriate alcohols; (b) chiral prep-HPLC separation; (c) 2 M HCl in diethyl ether, rt, 24 h, 64–80%.</p></p></figure><div class="NLM_p">Pharmacological profiles of the 5-fluoro compounds are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. All (+)-enantiomers had better efficacy than their (−)-enantiomers. However, a significant increase in potency at the 5-HT<sub>2C</sub> receptor was observed for these compounds compared to their 5-chloro analogues, while excellent selectivity was maintained. Compound (+)-<b>16a</b>, bearing an <i>n</i>-propyl group, displayed an EC<sub>50</sub> value of 11 nM at 5-HT<sub>2C</sub> and was 9-fold more potent than its 5-chloro analogue (+)-<b>13b</b> (EC<sub>50</sub> = 103 nM). It showed a high degree of selectivity over 5-HT<sub>2B</sub> (EC<sub>50</sub> = 1994 nM) and 5-HT<sub>2A</sub> (no activity). The allyl ether bearing derivative (+)-<b>16b</b> (EC<sub>50</sub> = 4.2 nM) has a potency equal to that of lorcaserin. It showed much better selectivity over 5-HT<sub>2B</sub> (no activity observed), with an 89-fold selectivity against 5-HT<sub>2A</sub> (EC<sub>50</sub> = 374 nM). The attachment of a fluorine atom to the allyl group, with the intent to enhance metabolic stability, led to (+)-<b>16c</b> that was slightly less potent at 5-HT<sub>2C</sub> (22 nM) but had an improved selectivity over 5-HT<sub>2A</sub>. The 2-fluoroethoxy bearing compound (+)-<b>16d</b> showed enhanced potency at 5-HT<sub>2C</sub> (EC<sub>50</sub> = 3.4 nM), along with excellent functional selectivity over both 5-HT<sub>2B</sub> (no activity observed) and 5-HT<sub>2A</sub> (>100-fold selectivity).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Efficacy and Selectivity Data of Compound <b>16a</b>–<b>16d</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Functional data were acquired with recombinant, stably expressed human 5-HT receptors in the HEK-293 cell line, using a fluorescence imaging plate reader (FLIPR) assay; “NA”, no activity at 10 μM.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">CLogP and LogBB values were calculated for the free bases using the ACD Percepta program.</p></div></div><div></div></div><div class="NLM_p">To further investigate their drug-like character, compounds (+)-<b>16b</b> and (+)-<b>16d</b> were tested for both CYP and hERG inhibition. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, improved CYP inhibition profiles were measured for (+)-<b>16b</b> and (+)-<b>16d</b> relative to compounds (+)-<b>13h</b>, (+)-<b>13j</b>, and (+)-<b>13l</b>. Less than 50% inhibition was observed at CYPs 3A4, 2D6, 2C9, and 2C19 for both compounds, while higher inhibition was observed at 2B6. As the 2B6 isoform is present in relatively low abundance in comparison to the other CYPs,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> these results are encouraging. In the hERG inhibition assay, although concentration-dependent inhibition was observed for (+)-<b>16b</b> and (+)-<b>16d</b>, both compounds afforded less than 50% inhibition at the highest concentration tested, which was 30 μM. These results suggest that the compounds may present a reasonable safety margin, as both compounds are active at the 5-HT<sub>2C</sub> receptor in the low nanomolar range.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. CYP and hERG Inhibition Data for Compounds (+)-<b>16b</b> and (+)-<b>16d</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">(+)-<b>16b</b></th><th class="colsep0 rowsep0" align="center" char=".">(+)-<b>16d</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition at 10 μM<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (%)</td><td class="colsep0 rowsep0" align="left">3A4</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2B6</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG inhibition<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (%)</td><td class="colsep0 rowsep0" align="left">0.37 μM</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.1 μM</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.3 μM</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10 μM</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30 μM</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">CYP inhibition test was performed using human liver microsomes; midazolam, dextromethorphan, tolbutamide, (<i>S</i>)-mephenytoin, and bupropion were used as test substrates for the 3A4, 2D6, 2C9, 2C19, and 2B6 isoforms, respectively.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">hERG inhibition was tested on CHO cells using the automated patch-clamp method.</p></div></div></div><div class="NLM_p last">Further pharmacological profiling was conducted for compounds (+)-<b>16b</b> and (+)-<b>16d</b> to investigate potential off-target activity. Binding studies were performed at 45 targets, including GPCRs, ion channels, neurotransmitter transporters, and sigma receptors, by the Psychoactive Drug Screening Program (PDSP). (+)-<b>16b</b> and (+)-<b>16d</b> were found to display high affinity for the 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors, with <i>K</i><sub>i</sub> values in the range of 30–50 nM. However, as already described, both compounds have been shown to be “functionally” selective for the 5-HT<sub>2C</sub> receptor. (+)-<b>16b</b> showed <1 μM <i>K</i><sub>i</sub> values at the 5-HT<sub>1A</sub>, 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, α<sub>2A</sub>, α<sub>2B</sub>, α<sub>2C</sub>, and dopamine D<sub>3</sub> receptor, while (+)-<b>16d</b> showed binding at this same level at only α<sub>2A</sub>. None of the other targets analyzed were found to show any significant off-target affinity for these two compounds (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S3">Supporting Information, Table S3</a>). Compared to the other known 5-HT<sub>2C</sub> agonists reported to date, compounds (+)-<b>16b</b> and (+)-<b>16d</b> thus represent attractive molecules in terms of both their 5-HT<sub>2C</sub> potency and selectivity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vivo Test in a Schizophrenia-like Animal Model</h3><div class="NLM_p">The pharmacological profiles and ADMET properties of the best compounds from both the 5-chloro and 5-fluoro series, (+)-<b>13j</b>, (+)-<b>13l</b>, (+)-<b>16b</b>, and (+)-<b>16d</b>, prompted their assessment in an animal model to explore their potential antipsychotic effects. One of the advantages of developing 5-HT<sub>2C</sub> agonists as antipsychotics is that they decrease levels of dopamine in limbic brain regions,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> which have been proven to mediate the antipsychotic effects of current antischizophrenia drugs. Meanwhile, agonism of the 5-HT<sub>2c</sub> receptor does not affect dopamine levels in the striatum, the region associated with extrapyramidal side effect of the “typical” antipsychotics.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Moreover, the antiobesity effect of 5-HT<sub>2C</sub> agonists is well-known, exemplified by the approval of lorcaserin as an antiobesity drug. Thus, these agonists do not have the potential side effect of weight gain, which is observed with many antipsychotics which have properties of 5-HT<sub>2C</sub> antagonists or inverse agonists.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Amphetamine-induced hyperactivity is a well-recognized rodent test used to assess the antipsychotic potential of a compound. To examine this possibility, compounds (+)-<b>13j</b>, (+)-<b>13l</b>, (+)-<b>16b</b>, and (+)-<b>16d</b> were tested in this model (details of the behavioral test are provided in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Adult male C57BL/6J mice were given the vehicle (Veh) or one of the test compounds and were placed into the open field for 15 min. They were removed and administered the Veh or <span class="smallcaps smallerCapital">d</span>-amphetamine (AMPH) and returned immediately to the open field for 105 min. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <span class="smallcaps smallerCapital">d</span>-amphetamine significantly increased locomotor activity from 16 to 120 min in the Veh–AMPH compared to the Veh–Veh group. Administration of each of the four compounds at the 10 or 20 mg/kg doses significantly reduced the AMPH-stimulated hyperlocomotion relative to the Veh–AMPH group (<i>p</i>-values <0.035). Although responses to 10 and 20 mg/kg (+)-<b>13l</b> and (+)-<b>16d</b> were not differentiated by dose, compounds (+)-<b>13j</b> and (+)-<b>16b</b> dose dependently suppressed the hyperactivity such that locomotion at the 20 mg/kg doses was similar to that of the Veh–Veh group. Importantly, the 20 mg/kg dose of each the four compounds alone (20-Veh groups) had little influence on the spontaneous activity of the injected animals. The reduction in AMPH-stimulated hyperlocomotion, especially by compounds (+)-<b>13j</b> and (+)-<b>16b</b>, indicate their potential as antipsychotic agents and encourage further studies of other behaviors.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cumulative locomotor activity following injection of the vehicle (Veh) or 3 mg/kg <span class="smallcaps smallerCapital">d</span>-amphetamine (AMPH). AMPH-stimulated locomotor activity in the Veh–AMPH group was higher than that in all other groups tested. Locomotion in the Veh–Veh group was similar to that in the (+)-<b>13j</b>–Veh, (+)-<b>13l</b>–Veh, (+)-<b>16b</b>–Veh, and (+)-<b>16d</b>–Veh groups (i.e., 20-Veh groups). Both 10 and 20 mg/kg of each of the four compounds decreased the AMPH-stimulated hyperlocomotion, with 20 mg/kg (+)-<b>13j</b> and (+)-<b>16b</b> being the most efficacious. <i>N</i> = 8–16 mice/group; *, <i>p</i> < 0.035, from the Veh–AMPH group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Homology Modeling to Elucidate the Binding Mode of Key Compounds to the 5-HT<sub>2C</sub> Receptor</h3><div class="NLM_p">Following our SAR studies, we wanted to obtain some idea as to how (+)-<b>16b</b> might interact with the 5-HT<sub>2C</sub> receptor. Thus, the 5-HT<sub>2C</sub> primary sequence was retrieved from UniProt (P28335, 5HT<sub>2C_HUMAN</sub>), and two 5-HT<sub>2C</sub> homology models were generated. The first model (5-HT<sub>2C_inact</sub>) was obtained using the β<sub>2</sub>-adrenergic receptor (β<sub>2</sub>-AR) as a template in its inactive state (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1">2RH1</a>), while the second model (5-HT<sub>2C_act</sub>) was generated by combining two templates, namely the resolved structure of 5-HT<sub>2B</sub> in a complex with ergotamine (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IB4">4IB4</a>) and the β<sub>2</sub>-AR in its fully active state (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SN6">3SN6</a>). This 5-HT<sub>2B</sub>–ergotamine model was selected due to the fact that ergotamine has functional selectivity for 5-HT<sub>2B</sub>, and thus the resolved structure does not represent a fully active state.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> By combining the two templates, the generated active model should benefit from the high homology in the orthosteric site between 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> while conserving features responsible for the fully activated state as taken from the β<sub>2</sub>-AR. The homology models were built by using Modeller9.12,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and the best structures were selected for docking studies. Docking simulations were performed using PLANTS, which finds plausible ligand poses through ant colony optimization algorithms (ACO).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (For details of the modeling study, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.)</div><div class="NLM_p">The macroscopic view of compound (+)-<b>16b</b> binding to both the inactive and active conformations of the 5-HT<sub>2C</sub> and the magnified views of the binding sites are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. As exemplified in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a, a significant difference was observed between the binding poses of compound (+)-<b>16b</b> with 5-HT<sub>2C_inactive</sub> and 5-HT<sub>2C_active</sub>, as the compound is inserted much deeper into a tighter niche when docking to 5-HT<sub>2C_active</sub>. As shown with the magnified view in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b, the computed complexes for the 5-HT<sub>2C_inact</sub> model are vastly stabilized by the ion pair between the ligand ammonium head and Asp134, a key contact reinforced by clear H-bonds with Ser138 and Tyr358 plus a charge transfer interaction with Trp130. By contrast, the remaining part of the ligand is seen to elicit only weak apolar contacts: (a) the cyclopropane ring approaches Ile131, (b) the phenyl ring is engaged in π–π stacking with Phe327, Trp355, and Tyr358, with the halogen atom approaching the indole nitrogen atom of Trp355, and (c) the alkenyl chain is stabilized by a possible π–π stacking interaction with Phe327.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding poses of compound (+)-<b>16b</b> in 5-HT<sub>2C</sub>. (a) Docking poses of compound (+)-<b>16b</b> in the 7-transmembrane domain (7TMD) of the 5-HT<sub>2C_inactive</sub> (compound shown in light yellow, protein shown in gray) and 5-HT<sub>2C_active</sub> (compound shown in orange, protein shown in green) conformations. (b) Magnified view of binding sites of compound (+)-<b>16b</b> in 5-HT<sub>2C_inactive</sub>. (c) Magnified view of binding sites of compound (+)-<b>16b</b> in 5-HT<sub>2C_active</sub>. (d) Overlay of compound (+)-<b>16b</b> (orange) with (+)-<b>13h</b> (sky blue) in the binding pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A significantly different interaction pattern is observed when analyzing the computed complexes for the 5-HT<sub>2C_act</sub> model. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c, the interactions involving the ligand ammonium group are almost superimposable on those seen using the inactive model and involve Asp134, Ser138, and Tyr358, while the cyclopropane ring elicits apolar contacts with Val135 and Val185. The largest differences between the two 5-HT<sub>2C</sub> models are observed for the contacts that stabilize the remaining portion of the ligands because the phenyl ring is inserted into a tight niche lined by aromatic residues (i.e., Phe214, Trp324, Phe327, Phe328, and Tyr358) with which it can interact via extended π–π stacking interactions, while the ether bridge engages in two possible H-bonds with Ser219 and Asn331. Finally, the alkenyl tail also engages in a possible π–π stacking interaction with Phe214.</div><div class="NLM_p">Some differences were also observed when the binding pose of (+)-<b>16b</b> was compared to that found for (+)-<b>13h</b>, as is apparent from the overlay shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d. The interactions displayed by the ammonium group of (+)-<b>13h</b> are superimposable to those of (+)-<b>16b</b>, but the positions of the benzene ring and the direction of the ether side chain are significantly different. The increase of steric hindrance upon changing the fluorine atom to a chlorine atom probably prevents the benzene ring from going deeper into the pocket, thus the ether side chain moves inside while the benzene ring is outside. The π–π stacking interactions within the tight niche lined by aromatic residues would therefore be anticipated to be weaker than those experienced by (+)-<b>16b</b>. This property might explain the fact that the potency of (+)-<b>16b</b> is about 15-fold higher than that of (+)-<b>13h</b> (4.2 vs 60 nM).</div><div class="NLM_p">When the binding mode of compound (+)-<b>16b</b> is compared to that of lorcaserin, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, (+)-<b>16b</b> shares with lorcaserin the same key interactions that stabilize the ammonium group as well as the extended set of hydrophobic and stacking contacts, with the cyclopropane ring suitably replacing the carbon skeleton of the benzazepine ring. The major differences in the 5-HT<sub>2C_act</sub> model is that the polar contact, namely the likely H-bond with Asn331, is seen only with compound (+)-<b>16b</b> because of its ether oxygen atom, while the chlorine atom of lorcaserin engages Asn331 in possible hydrophobic contacts.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of compound (+)-<b>16b</b> (orange) with lorcaserin (pink) in the binding pocket of 5-HT<sub>2C_active</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As our continuing efforts to optimize the 2-phenylcyclopropylmethylamine scaffold, new compounds bearing chlorine or fluorine substitutions at position 5 on the benzene ring were synthesized, and these modifications together with optimization of the ether substituent at position 2 led to compounds with good potency at the 5-HT<sub>2C</sub> receptor as well as improved selectivity against the 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub> receptors. In turn, ADMET studies coupled with behavioral analysis in the amphetamine-stimulated hyperlocomotion model identified four compounds with good profiles as antipsychotic agents. Compound (+)-<b>16b</b> displayed an EC<sub>50</sub> value of 4.2 nM at 5-HT<sub>2C</sub>, was 89-fold selective against 5-HT<sub>2A</sub>, and had no significant activity at 5-HT<sub>2B</sub>. It is one of the most potent and selective 5-HT<sub>2C</sub> agonists reported to date. At a dose of 20 mg/kg, (+)-<b>16b</b> completely reversed amphetamine-induced hyperactivity in mice while showing no significant influence on the spontaneous activity of the tested animals. Molecular modeling studies were also performed to elucidate the possible binding poses of compound (+)-<b>16b</b> to the 5-HT<sub>2C</sub> receptor, using a homology model incorporating both the well-known β<sub>2</sub>-adrenergic receptor template and recently reported 5-HT<sub>2B</sub> receptor.</div><div class="NLM_p last">The high potency and excellent selectivity profile of compound (+)-<b>16b</b>, together with its significant effects in an animal behavior study, strongly support the further evaluation of this compound as a chemical tool that can be used to elucidate the importance of the 5-HT<sub>2C</sub> receptors in normal human behaviors as well as in pathophysiological states. Further animal studies are being conducted to explore the use of this compound in the possible treatment of schizophrenia-like behaviors, and these studies will be reported separately.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General</h3><div class="NLM_p last">All chemicals and solvents were purchased from Sigma-Aldrich or Fisher Scientific and used without further purification. Microwave reactions were run in Biotage Initiator microwave synthesizer. Synthetic intermediates were purified by CombiFlash flash chromatography on 230–400 mesh silica gel. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Bruker DPX-400 or AVANCE-400 spectrometer at 400 and 100 MHz, respectively. NMR chemical shifts were reported in δ (ppm) using residual solvent peaks as standard (CDCl<sub>3</sub>, 7.26 ppm (<sup>1</sup>H), 77.23 ppm (<sup>13</sup>C); CD<sub>3</sub>OD, 3.31 ppm (<sup>1</sup>H), 49.15 ppm (<sup>13</sup>C); DMSO-<i>d</i><sub>6</sub>, 2.50 ppm (<sup>1</sup>H), 39.52 ppm (<sup>13</sup>C)). Mass spectra were measured in the ESI mode at an ionization potential of 70 eV with an LC-MS MSD (Hewlett-Packard). Purity of all final compounds (greater than 95%) was determined by analytical HPLC (ACE 3AQ C<sub>18</sub> column (150 mm × 4.6 mm, particle size 3 μM), 0.05% TFA in H<sub>2</sub>O/0.05% TFA in MeOH gradient eluting system). Optical rotation values were recorded on Autopol IV automatic polarimeter.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Method A: Preparation of <i>N</i>-Boc-amines <b>12a</b>–<b>12n</b> and <b>15a</b>–<b>15d</b></h3><div class="NLM_p last">Intermediate <b>11</b> and <b>14</b> was treated with the Williamson ether synthesis or Mitsunobu reaction conditions as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> (for detailed conditions, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Tables S1 and S2">Supporting Information, Tables S1 and S2</a>). The reactions were monitored with TLC, and the workup was done with ethyl acetate and water. Crude product was purified with flash chromatography.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Method B: Chiral Separation of <i>N</i>-Boc-amines <b>12a</b>–<b>12n</b> and <b>15a</b>–<b>15d</b></h3><div class="NLM_p last">The racemic intermediates were separated by chiral HPLC. Analytical conditions: RegisCell chiral column (25 cm × 4.6 mm, 10 μM), 1.5–15% EtOH in <i>n</i>-hexane as the fluent phase. Preparative conditions: RegisPack chiral column (25 cm × 21.1 mm, 10 μM), 3–7.5% EtOH in <i>n</i>-hexane as the eluting system (isocratic eluent, stacked injections, flow rate = 18 mL/min, λ = 254 and 280 nm). (+)-<b>12a</b>–<b>12n</b> and (+)-<b>15a</b>–<b>15d</b> were isolated as the first-eluting peaks, with (−)-<b>12a</b>–<b>12n</b> and (−)-<b>15a</b>–<b>15d</b> as the second-eluting peaks, both after evaporation appeared as colorless oil or white solids. Optical purity of both enantiomers was determined on analysis HPLC after the separation, and a second separation was done when necessary to guarantee >90% ee optical purity.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Method C: Deprotection of <i>N</i>-Boc-Amines to Afford HCl Salts (<b>13a</b>, <b>13b</b>, <b>13e</b>–<b>13g</b>, <b>13i</b>–<b>13n</b>, and <b>16a</b>–<b>16d</b>)</h3><div class="NLM_p last"><i>N</i>-Boc-Amines was dissolved in 2 M HCl (g) in diethyl ether (10 mL/mmol substrate) and stirred at room temperature for 24–48 h. The white solids formed were collected by filtration, washed with diethyl ether, and dried over vacuum to give the HCl salts as white solids.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Method D: Deprotection of <i>N</i>-Boc-Amines to Afford TFA Salts (<b>13c</b>, <b>13d</b>, and <b>13h</b>)</h3><div class="NLM_p">To a solution of the <i>N</i>-Boc protected precursor (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added to TFA (1 mL) at 0 °C under an argon atmosphere. The mixture was stirred at room temperature for 1 h. The reaction mixture was concentrated and the residue was dissolved in water and methanol (ratio 4:1). The solution was filtered and then purified by Shidmadzu preparative LC using the following conditions: ACE 5AQ column (150 mm × 21.2 mm, particle size 5 μM). Method: 8–100% 0.05% TFA in MeOH/0.05% TFA in H<sub>2</sub>O, 30 min. Flow rate = 17 mL/min with monitoring at 254 and 280 nm wavelengths. After the solvent was evaporated, the residue was dissolved in distilled water (2–3 mL) and lyophilized to obtain the TFA salt.</div><div class="NLM_p last">Detailed synthetic procedures were described for compounds (−)-<b>16b</b>, (+)-<b>16b</b>, (−)-<b>16d</b>, and (+)-<b>16d</b>. Other compounds were prepared similarly with the general methods described above and the characterization data are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>tert</i>-Butyl ((2-(2-(Allyloxy)-5-fluorophenyl)cyclopropyl)methyl)carbamate (<b>15b</b>)</h3><div class="NLM_p last">To a solution of compound <b>14</b> (282 mg, 1.0 mmol) in anhydrous DMF (2 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (489 mg, 1.5 mmol) and allyl bromide (242 mg, 2.0 mmol), and the mixture was heated in a microwave at 80 °C for 30 min. Water was added, and the mixture was extracted with ethyl acetate, the combined extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified with flash chromatography (0–30% ethyl acetate in hexanes) to render the title compound as a colorless oil (250 mg, 78%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.80 (dt, <i>J</i> = 8.8, 3.2 Hz, 1H), 6.75 (dd, <i>J</i> = 8.8, 4.8 Hz, 1H), 6.61 (dd, <i>J</i> = 9.2, 2.8 Hz), 6.18–6.08 (m, 1H), 5.42 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.31 (dd, <i>J</i> = 10.4, 1.2 Hz, 1H), 5.08 (br, 1H), 4.61–4.57 (m, 2H), 3.54–3.51 (m, 1H), 2.79–2.76 (m, 1H), 1.93–1.88 (m, 1H), 1.46 (s, 9H), 1.07–1.98 (m, 2H), 0.88–0.82 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.3 (d, <i>J</i><sub>CF</sub> = 236.9 Hz), 155.9, 153.5, 133.3, 132.6 (d, <i>J</i><sub>CF</sub> = 7.4 Hz), 118.1, 113.4 (d, <i>J</i><sub>CF</sub> = 23.3 Hz), 112.5 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 112.4 (d, <i>J</i><sub>CF</sub> = 8.4 Hz), 79.0, 69.8, 45.2, 28.5, 21.8, 17.0, 11.4. The racemate was separated with RegisPack chiral column (25 cm × 21.1 mm, 10 μM), 3.25% EtOH in <i>n</i>-hexane as the eluting system (isocratic eluent, stacked injections, flow rate = 18 mL/min, λ = 254 and 280 nm). (+)-<b>15b</b> (92 mg, 97% ee) was separated as the first peaks and (−)-<b>15b</b> (78 mg, 96% ee) as the second peaks. (+)-<b>15b</b>, [α]<sub>D</sub><sup>20</sup> +26.4 (<i>c</i> 0.5, CHCl<sub>3</sub>); (−)-<b>15b</b>, [α]<sub>D</sub><sup>20</sup> −26.8 (<i>c</i> 0.5, CHCl<sub>3</sub>).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (−)-((1<i>R</i>,2<i>R</i>)-2-(2-(Allyloxy)-5-fluorophenyl)cyclopropyl)methanamine Hydrochloride ((−)-<b>16b</b>)</h3><div class="NLM_p last">(+)-<b>15b</b> (80 mg, 0.25 mmol) was dissolved in 2 M HCl in diethyl ether (10 mL) and stirred at room temperature for 24 h. The precipitation was collected by filtration, washed with diethyl ether, and dried on vacuum to render the title compound as a white solid (48 mg, 75%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.93–6.86 (m, 2H), 6.73 (dd, <i>J</i> = 9.4, 3.2 Hz, 1H), 6.17–6.10 (m, 1H), 5.45 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.30 (dd, <i>J</i> = 10.4, 1.6 Hz, 1H), 4.60 (d, <i>J</i> = 5.6 Hz, 2H), 3.06 (dd, <i>J</i> = 13.2, 7.6 Hz, 1H), 2.98 (dd, <i>J</i> = 13.2, 4.2 Hz, 1H), 2.21–2.15 (m, 1H), 1.34–1.30 (m, 1H), 1.14–1.02 (m, 2H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 158.8 (d, <i>J</i><sub>CF</sub> = 225.7 Hz), 154.9, 135.0, 133.0(d, <i>J</i><sub>CF</sub> = 7.4 Hz), 118.2, 114.3 (d, <i>J</i><sub>CF</sub> = 17.8 Hz), 114.1, 114.0 (d, <i>J</i><sub>CF</sub> = 37.3 Hz), 71.0, 45.1, 19.7, 18.3, 13.7. HRMS (ESI) calculated for C<sub>13</sub>H<sub>17</sub>FNO ([M + H]<sup>+</sup>), 222.1294; found, 222.1273. [α]<sub>D</sub><sup>20</sup> −16.2 (<i>c</i> 0.4, MeOH).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (+)-((1<i>S</i>,2<i>S</i>)-2-(2-(Allyloxy)-5-fluorophenyl)cyclopropyl)methanamine Hydrochloride ((+)-<b>16b</b>)</h3><div class="NLM_p last">(−)-<b>15b</b> (60 mg, 0.19 mmol) was dissolved in 2 M HCl in diethyl ether (8 mL) and stirred at room temperature for 24 h. The precipitation was collected by filtration, washed with diethyl ether, and dried on vacuum to render the title compound as a white solid (32 mg, 66%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.93–6.86 (m, 2H), 6.73 (dd, <i>J</i> = 9.6, 3.2 Hz, 1H), 6.17–6.10 (m, 1H), 5.45 (dd, <i>J</i> = 17.2, 1.6 Hz, 1H), 5.30 (dd, <i>J</i> = 10.4, 1.6 Hz, 1H), 4.60 (d, <i>J</i> = 4.2 Hz, 2H), 3.07 (dd, <i>J</i> = 12.8, 7.2 Hz, 1H), 2.98 (dd, <i>J</i> = 13.2, 5.6 Hz, 1H), 2.21–2.17 (m, 1H), 1.35–1.31 (m, 1H), 1.14–1.04 (m, 2H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 158.8 (d, <i>J</i><sub>CF</sub> = 235.7 Hz), 155.0, 135.0, 133.0(d, <i>J</i><sub>CF</sub> = 7.4 Hz), 118.2, 114.3 (d, <i>J</i><sub>CF</sub> = 17.0 Hz), 114.1, 114.0 (d, <i>J</i><sub>CF</sub> = 36.1 Hz), 71.0, 45.1, 19.7, 18.3, 13.7. HRMS (ESI) calculated for C<sub>13</sub>H<sub>17</sub>FNO ([M + H]<sup>+</sup>), 222.1294; found, 222.1273. [α]<sub>D</sub><sup>20</sup> +17.5 (<i>c</i> 0.2, MeOH).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl ((2-(5-Fluoro-2-(2-fluoroethoxy)phenyl)cyclopropyl)methyl)carbamate (<b>15d</b>)</h3><div class="NLM_p last">To a solution of compound <b>14</b> (282 mg, 1.0 mmol), triphenylphosphine (787 mg, 3.0 mmol) and 2-fluoroethanol (192 mg, 3.0 mmol) in anhydrous THF (3 mL) was cooled at 0 °C and was added diethylazodicarboxylate (522 mg, 3.0 mmol) dropwise. The solution was then heated in microwave reactor at 60 °C for 40 min. The mixture was purified with flash chromatography (0–30% ethyl acetate in hexanes) after concentration to render <b>15d</b> as a colorless oil (320 mg, 98%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.82 (dt, <i>J</i> = 8.8, 2.8 Hz, 1H), 6.77 (dd, <i>J</i> = 8.0, 4.8 Hz, 1H), 6.62 (dd, <i>J</i> = 9.2, 2.8 Hz, 1H), 5.02 (br, 1H), 4.88–4.73 (m, 2H), 4.31–4.20 (m, 2H), 3.53–3.48 (m, 1H), 2.84–2.78 (m, 1H), 1.96–1.92 (m, 1H), 1.46 (s, 9H), 1.10–1.05 (m, 1H), 1.02–0.98 (m, 1H), 0.88–0.82 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.7 (d, <i>J</i><sub>CF</sub> = 237.5 Hz), 155.9, 153.4, 133.2 (d, <i>J</i><sub>CF</sub> = 7.4 Hz), 113.5 (d, <i>J</i><sub>CF</sub> = 23.4 Hz), 112.9 (d, <i>J</i><sub>CF</sub> = 8.5 Hz), 112.6 (d, <i>J</i><sub>CF</sub> = 22.7 Hz), 81.9 (d, <i>J</i><sub>CF</sub> = 169.7 Hz), 79.1, 68.5 (d, <i>J</i><sub>CF</sub> = 20.2 Hz), 45.1, 28.5, 20.0, 16.8, 11.5. The racemate was separated with RegisPack chiral column (25 cm × 21.1 mm, 10 μM), 7.5% EtOH in <i>n</i>-hexane as the eluting system (isocratic eluent, stacked injections, flow rate = 18 mL/min, λ = 254 and 280 nm). (+)-<b>15d</b> (120 mg, > 99% ee) was separated as the first peaks and (−)-<b>15d</b> (110 mg, > 99% ee) as the second peaks. (+)-<b>15d</b>, [α]<sub>D</sub><sup>20</sup> +20.2 (<i>c</i> 0.3, CHCl<sub>3</sub>); (−)-<b>15d</b>, [α]<sub>D</sub><sup>20</sup> −18.7 (<i>c</i> 0.3, CHCl<sub>3</sub>).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (−)-((1<i>R</i>,2<i>R</i>)-2-(5-Fluoro-2-(2-fluoroethoxy)phenyl)cyclopropyl)methanamine Hydrochloride ((−)-<b>16d</b>)</h3><div class="NLM_p last">Compound (+)-<b>15d</b> (110 mg, 0.34 mmol) was dissolved in 2 M HCl in diethyl ether (8 mL) and stirred at room temperature for 24 h. The precipitation was collected by filtration, washed with diethyl ether, and dried on vacuum to render the title compound as a white solid (61 mg, 69%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.97–6.86 (m, 2H), 6.76 (dd, <i>J</i> = 9.2, 2.8 Hz, 1H), 4.87–4.75 (m, 2H), 4.32–4.20 (m, 2H), 3.04–3.00 (m, 2H), 2.19–2.15 (m, 1H), 1.28–1.17 (m, 2H), 1.06–1.02 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 159.0 (d, <i>J</i><sub>CF</sub> = 236.0 Hz), 155.0, 133.0 (d, <i>J</i><sub>CF</sub> = 7.4 Hz), 114.6 (d, <i>J</i><sub>CF</sub> = 24.0 Hz), 114.2 (d, <i>J</i><sub>CF</sub> = 22.8 Hz), 114.0 (d, <i>J</i><sub>CF</sub> = 8.1 Hz), 83.6 (d, <i>J</i><sub>CF</sub> = 166.6 Hz), 69.7 (d, <i>J</i><sub>CF</sub> = 18.9 Hz), 45.0, 20.0, 18.3, 13.0. HRMS (ESI) calculated for C<sub>12</sub>H<sub>16</sub>F<sub>2</sub>NO ([M + H]<sup>+</sup>), 228.1200; found, 228.1179. [α]<sub>D</sub><sup>20</sup> −3.3 (<i>c</i> 0.3, MeOH).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (+)-((1<i>S</i>,2<i>S</i>)-2-(5-Fluoro-2-(2-fluoroethoxy)phenyl)cyclopropyl)methanamine Hydrochloride ((+)-<b>16d</b>)</h3><div class="NLM_p last">This compound was prepared from (−)-<b>15d</b> as described for (−)-<b>16d</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 6.97–6.88 (m, 2H), 6.76 (dd, <i>J</i> = 9.6, 3.2 Hz, 1H), 4.87–4.74 (m, 2H), 4.32–4.22 (m, 2H), 3.03 (d, <i>J</i> = 7.6 Hz, 2H), 2.20–2.15 (m, 1H), 1.28–1.25 (m, 1H), 1.22–1.17 (m, 1H), 1.07–1.02 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 159.0 (d, <i>J</i><sub>CF</sub> = 236.2 Hz), 155.0, 133.1 (d, <i>J</i><sub>CF</sub> = 7.3 Hz), 114.6 (d, <i>J</i><sub>CF</sub> = 24.0 Hz), 114.2 (d, <i>J</i><sub>CF</sub> = 17.5 Hz), 114.1 (d, <i>J</i><sub>CF</sub> = 3.1 Hz), 83.6 (d, <i>J</i><sub>CF</sub> = 166.6 Hz), 69.7 (d, <i>J</i><sub>CF</sub> = 19.8 Hz), 45.0, 20.0, 18.3, 13.1. HRMS (ESI) calculated for C<sub>12</sub>H<sub>16</sub>F<sub>2</sub>NO ([M + H]<sup>+</sup>), 228.1200; found, 228.1173. [α]<sub>D</sub><sup>20</sup> +3.6 (<i>c</i> 0.3, MeOH).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Calcium Flux Assay</h3><div class="NLM_p last">Flp-In-293 cells stably expressing the human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, or 5-HT<sub>2C-INI</sub> were grown for 24–48 h in DMEM containing 10% dialyzed FBS before seeding. Cells were plated into Poly-<span class="smallcaps smallerCapital">l</span>-Lys-coated 384-well black clear bottom cell culture plates in DMEM with 1% dialyzed FBS at a density of 12000 cells per 50 μL per well for 24 h. Preceding the experiment, culture medium was removed and 20 μL of assay buffer (20 mM Hepes, pH 7.40, Hanks’ balanced salt solution, 2.5 mM probenecid, 1× FLIPR calcium dye) was added and cells were incubated at 37 °C for 1 h. Serial dilutions of each tested drug were prepared at 3× final concentration and transferred to 384-well plates. Each drug plate contained 5-HT and lorcaserin in serial dilutions for internal reference. Cell and drug plates were placed in a FLIPR<sup>TETRA</sup> fluorescence imaging plate reader (Molecular Dynamics). The FLIPR<sup>TETRA</sup> was programmed to read baseline for 10 s (1 read/s) and then add 10 μL of drug/well and read for an additional 120 s. Fluorescence was normalized to the average of the baseline (first 10 reads), and the maximum fold increase peak was determined for each drug and controls (5-HT and lorcaserin). Data were plotted as a function of drug concentration and were normalized compared to the internal 5-HT reference for each plate recorded. Normalized data were regressed using a sigmoidal dose–response function. Data of two independent experiments (<i>n</i> = 2) conducted in quadruplicate are presented. Analyses were performed using the software from GraphPad Prism 6.0. 5-HT<sub>2C</sub> EC<sub>50</sub> confidence intervals (5-HT, 0.16–0.26 nM; lorcaserin, 3.1–3.9 nM), <i>E</i><sub>max</sub> Std Error (5-HT, 100% ± 1.04; lorcaserin, 99% ± 0.75); 5-HT<sub>2B</sub> EC<sub>50</sub> confidence intervals (5-HT, 0.66–1.17 nM; lorcaserin, 429–527 nM), <i>E</i><sub>max</sub> Std Error (5-HT, 100% ± 1.69; lorcaserin, 92% ± 3.01); 5-HT<sub>2A</sub> EC<sub>50</sub> confidence intervals (5-HT, 1.60–2.16 nM; lorcaserin, 275–329 nM), <i>E</i><sub>max</sub> Std Error (5-HT, 100% ± 1.03; lorcaserin, 68% ± 0.83).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Open Field Activity</h3><div class="NLM_p last">Adult male C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were injected (ip) with the vehicle (Veh, 0.9% saline from Butler Schein Animal Health, Dublin, Ohio) or different doses of compounds (+)-<b>13j</b>, (+)-<b>13l</b>, (+)-<b>16b</b>, or (+)-<b>16d</b> (compounds were dissolved in 0.9% saline and injected intraperitoneally at 5 mL/kg) and placed into the open field for 15 min. The mice were removed and administered (ip) the Veh or 3 mg/kg amphetamine (AMPH; Sigma-Aldrich, St. Louis, MO) and returned to the open field for 105 min. Locomotor activity was monitored as distance traveled in an automated Omnitech Digiscan apparatus using VersaMax software (AccuScan Instruments, Columbus, OH). The results are presented as means and standard errors of the mean using SPSS software (IBM, Armonk, NY). The data from the 0–15 min interval were analyzed by three-way ANOVA for condition (vehicle and AMPH), treatment (compounds (+)-<b>13j</b>, (+)-<b>13l</b>, (+)-<b>16b</b>, and (+)-<b>16d</b>), dose (10 or 20 mg/kg), and dose nested in treatment (to reflect the different doses tested per compound). Because activities among the groups at the 0–15 min interval were significantly different, a RMANOVA was run with a sequential sum of squares (to control for the group differences at 0–15 min) for test interval (0–15 and 16–120 min), condition, treatment, dose, and dose (treatment) to control for these group differences. All posthoc analyses were by Bonferroni corrected pairwise comparisons where a <i>p</i> < 0.05 was considered significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29"><a href="/doi/suppl/10.1021/jm5019274">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13563" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13563" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Reaction conditions for the preparation of <b>12a</b>–<b>12n</b> and <b>15a</b>–<b>15d</b> intermediates, characterization data for all other compounds, pharmacological profiling data of compounds (+)-<b>16b</b> and (+)-<b>16d</b>, and details of the modeling study. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5019274/suppl_file/jm5019274_si_001.pdf">jm5019274_si_001.pdf (693.8 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5019274" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan P. Kozikowski</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#690206130002061e08291c000a470c0d1c"><span class="__cf_email__" data-cfemail="2a4145504341455d4b6a5f4349044f4e5f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianjun Cheng</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick M. Giguère</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Mental Health Psychoactive Drug Screening Program, Department
of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oluseye K. Onajole</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Lv</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arsen Gaisin</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hendra Gunosewoyo</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Program, Department of Medicinal Chemistry and Pharmacognosy,
College of Pharmacy, University of Illinois
at Chicago, 833 South
Wood Street, Chicago, Illinois 60612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire M. Schmerberg</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Mouse Behavioral and Neuroendocrine
Analysis Core Facility, Duke University
Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir M. Pogorelov</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Mouse Behavioral and Neuroendocrine
Analysis Core Facility, Duke University
Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramona M. Rodriguiz</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry and Behavioral Sciences, Mouse Behavioral and Neuroendocrine
Analysis Core Facility, Duke University
Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giulio Vistoli</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze Farmaceutiche, Università
degli Studi di Milano, Via Mangiagalli 25, 20133 Milano, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William C. Wetsel</span> - <span class="hlFld-Affiliation affiliation">Departments
of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology,
Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan L. Roth</span> - <span class="hlFld-Affiliation affiliation">National
Institute of Mental Health Psychoactive Drug Screening Program, Department
of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, North Carolina 27599, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3380e3428-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support from the National Institute of Health (NIH) (no. R01MH99993) and NIMH Psychoactive Drug Screening Program is gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35"> Abbreviations Used</h2><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">serotonin</p></td></tr><tr><td class="NLM_term">β<sub>2</sub>-AR</td><td class="NLM_def"><p class="first last">β<sub>2</sub>-adrenergic receptor</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion and toxicity</p></td></tr><tr><td class="NLM_term">AMPH</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">d</span>-amphetamine</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary cells</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">US Food and Drug Administration</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorescence imaging plate reader</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptor</p></td></tr><tr><td class="NLM_term">HEK-293</td><td class="NLM_def"><p class="first last">human embryonic kidney 293 cells</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane</p></td></tr><tr><td class="NLM_term">TMD</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr><tr><td class="NLM_term">Veh</td><td class="NLM_def"><p class="first last">vehicle</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The expanded biology of serotonin</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1146%2Fannurev.med.60.042307.110802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=19630576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=355-366&author=M.+Bergerauthor=J.+A.+Grayauthor=B.+L.+Roth&title=The+expanded+biology+of+serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The expanded biology of serotonin</span></div><div class="casAuthors">Berger, Miles; Gray, John A.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-366</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin is perhaps best known as a neurotransmitter that modulates neural activity and a wide range of neuropsychol. processes, and drugs that target serotonin receptors are used widely in psychiatry and neurol.  However, most serotonin is found outside the central nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as within the brain.  Serotonin regulates numerous biol. processes including cardiovascular function, bowel motility, ejaculatory latency, and bladder control.  Addnl., new work suggests that serotonin may regulate some processes, including platelet aggregation, by receptor-independent, transglutaminase-dependent covalent linkage to cellular proteins.  We review this new expanded serotonin biol. and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoz0HW5hdNOrVg90H21EOLACvtfcHk0lhrWIJD7jUIuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D&md5=0557e01e6b79dbfb50559aca03f8b31f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.60.042307.110802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.60.042307.110802%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520expanded%2520biology%2520of%2520serotonin%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2009%26volume%3D60%26spage%3D355%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. D.</span><span> </span><span class="NLM_article-title">Serotonin receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr078224o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1614-1641&author=D.+E.+Nicholsauthor=C.+D.+Nichols&title=Serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin Receptors</span></div><div class="casAuthors">Nichols, David E.; Nichols, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1614-1641</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on phylogeny, structural features, oligomerization, classification and functions of serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnlR5CHbuX7Vg90H21EOLACvtfcHk0lhrWIJD7jUIuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D&md5=55b70829f6be71cbfe4de05c5ef665d8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fcr078224o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr078224o%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DNichols%26aufirst%3DC.%2BD.%26atitle%3DSerotonin%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1614%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4986-4991&author=H.+Y.+Meltzerauthor=B.+L.+Roth&title=Lorcaserin+and+pimavanserin%3A+emerging+selectivity+of+serotonin+receptor+subtype-targeted+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DLorcaserin%2520and%2520pimavanserin%253A%2520emerging%2520selectivity%2520of%2520serotonin%2520receptor%2520subtype-targeted%2520drugs%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4986%26epage%3D4991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Smith, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span> </span><span class="NLM_article-title">The potential use of selective 5-HT2C agonists in treating obesity</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1517%2F13543784.15.3.257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=16503763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVKns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=257-266&author=B.+M.+Smithauthor=W.+J.+Thomsenauthor=A.+J.+Grottick&title=The+potential+use+of+selective+5-HT2C+agonists+in+treating+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The potential use of selective 5-HT2C agonists in treating obesity</span></div><div class="casAuthors">Smith, Brian M.; Thomsen, William J.; Grottick, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Activation of central 5-HT2C receptors as a strategy for appetite suppression and wt. control is supported by animal pharmacol. and human clin. studies.  Considerable evidence comes from the wt.-loss effects of fenfluramine, a non-selective 5-HT2C agonist.  Advances in mol. pharmacol. have led to an understanding of the effects of 5-HT2C receptor activation on food intake and satiety, in addn. to providing insight into the causes of cardiac valvular insufficiency and pulmonary hypertension assocd. with the use of fenfluramine.  However, clin. validated animal models of drug-induced disease and knowledge of the mol. mechanisms of these safety issues is lacking.  For this reason, the development of selective 5-HT2C agonists for the treatment of obesity has remained a challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq33JUfMDIf8LVg90H21EOLACvtfcHk0lgEYX5fVdpf2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVKns7s%253D&md5=902b389c885f6b321e7baf69ebcfdfcb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543784.15.3.257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.15.3.257%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BM.%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520potential%2520use%2520of%2520selective%25205-HT2C%2520agonists%2520in%2520treating%2520obesity%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D15%26spage%3D257%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sargent, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span> </span><span class="NLM_article-title">Targeting 5-HT receptors for the treatment of obesity</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2Fj.coph.2011.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=21330209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=52-58&author=B.+J.+Sargentauthor=A.+J.+Henderson&title=Targeting+5-HT+receptors+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting 5-HT receptors for the treatment of obesity</span></div><div class="casAuthors">Sargent, Bruce J.; Henderson, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is known to have anorectic properties through centrally acting mechanisms.  Three serotonin receptors have been implicated in mediating these effects: 5-HT1B, 5-HT2C and 5-HT6.  Hypophagic effects are elicited through agonism of the former two receptors, whereas antagonism of the 5-HT6 receptor appears to have an anorectic effect.  All three targets have been validated through extensive studies including knockout mice and selective ligand assessment.  5-HT1B receptor agonists have limited utility due to mechanism-based side effects, whereas 5-HT2C receptor agonists suffer from challenges assocd. with selectivity over the closely related 5-HT2A and 5-HT2B receptors.  5-HT6 receptor antagonists appear to offer great promise, although the mechanisms through which they reduce food intake and body wt. are not fully understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7HpGhwkLC1LVg90H21EOLACvtfcHk0lgEYX5fVdpf2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D&md5=6f7344a29e985af4a08d76626dc6d8f9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%25205-HT%2520receptors%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D52%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span> </span><span class="NLM_article-title">5-HT(2C) agonists as therapeutics for the treatment of schizophrenia</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1007%2F978-3-642-25758-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=23027415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=147-165&author=S.+Rosenzweig-Lipsonauthor=T.+A.+Comeryauthor=K.+L.+Marquisauthor=J.+Grossauthor=J.+Dunlop&title=5-HT%282C%29+agonists+as+therapeutics+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C agonists as therapeutics for the treatment of schizophrenia</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Comery, Thomas A.; Marquis, Karen L.; Gross, Jonathan; Dunlop, John</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">147-165</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The 5-HT2C receptor is a highly complex, highly regulated receptor which is widely distributed throughout the brain.  The 5-HT2C receptor couples to multiple signal transduction pathways leading to engagement of a no. of intracellular signaling mols.  Moreover, there are multiple allelic variants of the 5-HT2C receptor and the receptor is subject to RNA editing in the coding regions.  The complexity of this receptor is further emphasized by the studies suggesting the utility of either agonists or antagonists in the treatment of schizophrenia.  While several 5-HT2C agonists have demonstrated clin. efficacy in obesity (lorcaserin, PRX-000933), the focus of this review is on the therapeutic potential of 5-HT2C agonists in schizophrenia.  To this end, the preclin. profile of 5-HT2C agonists from a neurochem., electrophysiol., and a behavioral perspective is indicative of antipsychotic-like efficacy without extrapyramidal symptoms or wt. gain.  Recently, the selective 5-HT2C agonist vabicaserin demonstrated clin. efficacy in a Phase II trial in schizophrenia patients without wt. gain and with low EPS liability.  These data are highly encouraging and suggest that 5-HT2C agonists are potential therapeutics for the treatment of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuqzYsH56GbVg90H21EOLACvtfcHk0lgEYX5fVdpf2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D&md5=17bdc34317a7d966bc6038bca83ec5b3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26atitle%3D5-HT%25282C%2529%2520agonists%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26spage%3D147%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mombereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundersen, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span> </span><span class="NLM_article-title">Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=468-473&author=C.+Mombereauauthor=Y.+Kawaharaauthor=B.+B.+Gundersenauthor=K.+Nishikuraauthor=J.+A.+Blendy&title=Functional+relevance+of+serotonin+2C+receptor+mRNA+editing+in+antidepressant-+and+anxiety-like+behaviors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMombereau%26aufirst%3DC.%26aulast%3DKawahara%26aufirst%3DY.%26aulast%3DGundersen%26aufirst%3DB.%2BB.%26aulast%3DNishikura%26aufirst%3DK.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26atitle%3DFunctional%2520relevance%2520of%2520serotonin%25202C%2520receptor%2520mRNA%2520editing%2520in%2520antidepressant-%2520and%2520anxiety-like%2520behaviors%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D59%26spage%3D468%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pazos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J. M.</span><span> </span><span class="NLM_article-title">The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2F0014-2999%2884%2990057-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=6519175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADyaL2MXptVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1984&pages=539-546&author=A.+Pazosauthor=D.+Hoyerauthor=J.+M.+Palacios&title=The+binding+of+serotonergic+ligands+to+the+porcine+choroid+plexus%3A+characterization+of+a+new+type+of+serotonin+recognition+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The binding of serotonergic ligands to the porcine choroid plexus:  characterization of a new type of serotonin recognition site</span></div><div class="casAuthors">Pazos, Angel; Hoyer, Daniel; Palacios, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">539-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The kinetic and pharmacol. characteristics of the binding of 3H-labeled 5-HT  [50-67-9], [3H]8-hydroxy-2-di-n-propylaminotetraline, [3H]LSD, [3H]ketanserin, and 3H-labeled mesulergine  [64795-35-3] to membranes from frontal cortex, hippocampus, and choroid plexus of pig brain were studied.  The binding of these ligands to frontal cortex and hippocampus demonstrated the presence of 5-HT1 and 5-HT2 sites in both tissues, although hippocampus was richer in 5-HT1 (subtype 5-HT1A) sites.  [3H]5-HT, [3H]mesulergine, and [3H]LSD labeled the pig choroid plexus with high affinity.  The pharmacol. profiles of [3H]5-HT and [3H]mesulergine binding to this tissue were closely comparable.  Ligands reported as selective for 5-HT1A, 5-HT1B, or 5-HT2 subtypes did not show high affinity for these binding sites.  Therefore, these 5-HT binding sites in pig choroid plexus could be named 5-HT1c.  Other drugs with a high affinity for these sites were methysergide and mianserine.  In pig frontal cortex, [3H]5-HT labeled the different subtypes of 5-HT1 sites.  In contrast, [3H]mesulergine bound in pig frontal cortex to a small population of sites with pharmacol. properties similar to those of the choroid plexus 5-HT1c sites.  Possible physiol. functions in which these sites might be involved are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0l961cuMHyLVg90H21EOLACvtfcHk0lgX10GEScaneA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXptVGjuw%253D%253D&md5=bdbf81bd51d54e7238632a6c506dafab</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2884%2990057-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252884%252990057-8%26sid%3Dliteratum%253Aachs%26aulast%3DPazos%26aufirst%3DA.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520binding%2520of%2520serotonergic%2520ligands%2520to%2520the%2520porcine%2520choroid%2520plexus%253A%2520characterization%2520of%2520a%2520new%2520type%2520of%2520serotonin%2520recognition%2520site%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1984%26volume%3D106%26spage%3D539%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Berg, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, U.</span><span> </span><span class="NLM_article-title">Fine-tuning serotonin 2c receptor function in the brain: molecular and functional implications</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=969-976&author=K.+A.+Bergauthor=W.+P.+Clarkeauthor=K.+A.+Cunninghamauthor=U.+Spampinato&title=Fine-tuning+serotonin+2c+receptor+function+in+the+brain%3A+molecular+and+functional+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DSpampinato%26aufirst%3DU.%26atitle%3DFine-tuning%2520serotonin%25202c%2520receptor%2520function%2520in%2520the%2520brain%253A%2520molecular%2520and%2520functional%2520implications%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D969%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">Hallucinogens</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2Fj.pharmthera.2003.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=14761703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=131-181&author=D.+E.+Nichols&title=Hallucinogens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hallucinogens</span></div><div class="casAuthors">Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-181</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Hallucinogens (psychedelics) are psychoactive substances that powerfully alter perception, mood, and a host of cognitive processes.  They are considered physiol. safe and do not produce dependence or addiction.  Their origin predates written history, and they were employed by early cultures in a variety of sociocultural and ritual contexts.  In the 1950s, after the virtually contemporaneous discovery of both serotonin (5-HT) and lysergic acid diethylamide (LSD-25), early brain research focused intensely on the possibility that LSD or other hallucinogens had a serotonergic basis of action and reinforced the idea that 5-HT was an important neurotransmitter in brain.  These ideas were eventually proven, and today it is believed that hallucinogens stimulate 5-HT2A receptors, esp. those expressed on neocortical pyramidal cells.  Activation of 5-HT2A receptors also leads to increased cortical glutamate levels presumably by a presynaptic receptor-mediated release from thalamic afferents.  These findings have led to comparisons of the effects of classical hallucinogens with certain aspects of acute psychosis and to a focus on thalamocortical interactions as key to understanding both the action of these substances and the neuroanatomical sites involved in altered states of consciousness (ASC).  In vivo brain imaging in humans using [18F]fluorodeoxyglucose has shown that hallucinogens increase prefrontal cortical metab., and correlations have been developed between activity in specific brain areas and psychol. elements of the ASC produced by hallucinogens.  The 5-HT2A receptor clearly plays an essential role in cognitive processing, including working memory, and ligands for this receptor may be extremely useful tools for future cognitive neuroscience research.  In addn., it appears entirely possible that utility may still emerge for the use of hallucinogens in treating alcoholism, substance abuse, and certain psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRl6lKmZ_4Y7Vg90H21EOLACvtfcHk0lgX10GEScaneA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D&md5=7b5246f6479d76736c5a7223c60a9e99</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2003.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2003.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DHallucinogens%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D101%26spage%3D131%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">5-HT2C receptor modulators: a patent survey</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1517%2F13543776.2010.518956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=20849206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1429-1455&author=J.+Leeauthor=M.+E.+Jungauthor=J.+Lee&title=5-HT2C+receptor+modulators%3A+a+patent+survey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor modulators: a patent survey</span></div><div class="casAuthors">Lee, Junwon; Jung, Myung Eun; Lee, Jinhwa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1455</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT2C receptor is a GPCR and is one of the 14 subtypes that constitute the serotonin receptor family.  The 5-HT2C receptor is exclusively expressed in the CNS where it demonstrates a wide distribution and displays high-affinity interactions with a wide variety of psychiatric medications.  Modulators of 5-HT2C have been implicated as a potential treatment for diseases of significant unmet medical need, including obesity, schizophrenia, depression, anxiety, Parkinson's disease, drug addiction, erectile dysfunction and urinary incontinence.  Thus, there is a great interest in developing potent and selective 5-HT2C receptor modulators.  Areas covered in this review: This review article highlights the research progress in 5-HT2C receptor modulators published in the patent literature between Jan. 2003 and June 2010, giving emphasis to the medicinal chemist's standpoint.  What the reader will gain: Readers will rapidly gain an overview of the various 5-HT2C receptor modulators reported in the patent literature in the past 8 years.  Furthermore, the readers will learn which structure type can interact with the 5-HT2C receptor.  In addn., the readers will be aware of the pharmaceutical companies that have been the main players in the field.  Take home message: There is substantial evidence supporting the concept that a selective 5-HT2C receptor modulator should provide benefit in the treatment of a variety of CNS disorders.  Although research efforts have identified several promising 5-HT2C receptor modulators that display high functional selectivity, further clin. efficacy and safety data are needed to prove their actual clin. utility.  Therefore, the query for selectively acting 5-HT2C receptor modulators is still ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsaQEKrg_R7Vg90H21EOLACvtfcHk0liwV_IL2Raf6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF&md5=43397f74d27751efdc505165ba96172c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3D5-HT2C%2520receptor%2520modulators%253A%2520a%2520patent%2520survey%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1429%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Thomsen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzaghi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Saldana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espitia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuskin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D.</span><span> </span><span class="NLM_article-title">Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1124%2Fjpet.107.133348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=18252809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=577-587&author=W.+J.+Thomsenauthor=A.+J.+Grottickauthor=F.+Menzaghiauthor=H.+Reyes-Saldanaauthor=S.+Espitiaauthor=D.+Yuskinauthor=K.+Whelanauthor=M.+Martinauthor=M.+Morganauthor=W.+Chenauthor=H.+Al-Shammaauthor=B.+Smithauthor=D.+Chalmersauthor=D.+Behan&title=Lorcaserin%2C+a+novel+selective+human+5-hydroxytryptamine2C+agonist%3A+in+vitro+and+in+vivo+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization</span></div><div class="casAuthors">Thomsen, William J.; Grottick, Andrew J.; Menzaghi, Frederique; Reyes-Saldana, Hazel; Espitia, Stephen; Yuskin, Diane; Whelan, Kevin; Martin, Michael; Morgan, Michael; Chen, Weichao; Al-Shamma, Hussein; Smith, Brian; Chalmers, Derek; Behan, Dominic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">577-587</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)2C receptor agonists hold promise for the treatment of obesity.  In this study, we describe the in vitro and in vivo characteristics of lorcaserin [(1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3 benzazepine], a selective, high affinity 5-HT2C full agonist.  Lorcaserin bound to human and rat 5-HT2C receptors with high affinity (Ki = 15±1 nM, 29±7 nM, resp.), and it was a full agonist for the human 5-HT2C receptor in a functional inositol phosphate accumulation assay, with 18- and 104-fold selectivity over 5-HT2A and 5-HT2B receptors, resp.  Lorcaserin was also highly selective for human 5-HT2C over other human 5-HT receptors (5-HT1A, 5-HT3, 5-HT4C, 5-HT55A, 5-HT6, and 5-HT7), in addn. to a panel of 67 other G protein-coupled receptors and ion channels.  Lorcaserin did not compete for binding of ligands to serotonin, dopamine, and norepinephrine transporters, and it did not alter their function in vitro.  Behavioral observations indicated that unlike the 5-HT2A agonist (±)-1-(2,5-dimethoxy-4-phenyl)-2-aminopropane, lorcaserin did not induce behavioral changes indicative of functional 5-HT2A agonist activity.  Acutely, lorcaserin reduced food intake in rats, an effect that was reversed by pretreatment with the 5-HT2C-selective antagonist 6-chloro-5-methyl-1-[6-(2-methylpyridin-3-yloxy)pyridin-3-yl-carbamoyl]indoline (SB242,084) but not the 5-HT2A antagonist (R)-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol (MDL 100,907), demonstrating mediation by the 5-HT2C receptor.  Chronic daily treatment with lorcaserin to rats maintained on a high fat diet produced dose-dependent redns. in food intake and body wt. gain that were maintained during the 4-wk study.  Upon discontinuation, body wt. returned to control levels.  These data demonstrate lorcaserin to be a potent, selective, and efficacious agonist of the 5-HT2C receptor, with potential for the treatment of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqDHE28aF3k7Vg90H21EOLACvtfcHk0liwV_IL2Raf6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D&md5=0626c3dabb7e89066e45ecd12cbc81f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133348%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DMenzaghi%26aufirst%3DF.%26aulast%3DReyes-Saldana%26aufirst%3DH.%26aulast%3DEspitia%26aufirst%3DS.%26aulast%3DYuskin%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DChalmers%26aufirst%3DD.%26aulast%3DBehan%26aufirst%3DD.%26atitle%3DLorcaserin%252C%2520a%2520novel%2520selective%2520human%25205-hydroxytryptamine2C%2520agonist%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D577%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span> </span><span class="NLM_article-title">Lorcaserin. In obesity: unacceptable risks</span>.  <span class="citation_source-journal">Prescrire Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=24926508" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lorcaserin.+In+obesity%3A+unacceptable+risks.+Prescrire+Int.+2014%2C+23%2C+117%E2%80%93120."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DLorcaserin.%2520In%2520obesity%253A%2520unacceptable%2520risks%26jtitle%3DPrescrire%2520Int.%26date%3D2014%26volume%3D23%26spage%3D117%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, H.</span><span> </span><span class="NLM_article-title">Prediction of Efficacy of Vabicaserin, a 5-HT2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model</span> <span class="citation_source-journal">CPT Pharmacometrics Syst. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=e111&author=J.+Liuauthor=A.+Ogdenauthor=T.+A.+Comeryauthor=A.+Spirosauthor=P.+Robertsauthor=H.+Geerts&title=Prediction+of+Efficacy+of+Vabicaserin%2C+a+5-HT2C+Agonist%2C+for+the+Treatment+of+Schizophrenia+Using+a+Quantitative+Systems+Pharmacology+Model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DOgden%26aufirst%3DA.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DSpiros%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DP.%26aulast%3DGeerts%26aufirst%3DH.%26atitle%3DPrediction%2520of%2520Efficacy%2520of%2520Vabicaserin%252C%2520a%25205-HT2C%2520Agonist%252C%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%2520Using%2520a%2520Quantitative%2520Systems%2520Pharmacology%2520Model%26jtitle%3DCPT%2520Pharmacometrics%2520Syst.%2520Pharmacol.%26date%3D2014%26volume%3D3%26spage%3De111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawoschik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1124%2Fjpet.111.179572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=21402690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFeiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2011&pages=673-680&author=J.+Dunlopauthor=S.+W.+Wattsauthor=J.+E.+Barrettauthor=J.+Coupetauthor=B.+Harrisonauthor=H.+Mazandaraniauthor=S.+Nawoschikauthor=M.+N.+Pangalosauthor=S.+Ramamoorthyauthor=L.+Schechterauthor=D.+Smithauthor=G.+Stackauthor=J.+Zhangauthor=G.+Zhangauthor=S.+Rosenzweig-Lipson&title=Characterization+of+vabicaserin+%28SCA-136%29%2C+a+selective+5-hydroxytryptamine+2C+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist</span></div><div class="casAuthors">Dunlop, John; Watts, Stephanie W.; Barrett, James E.; Coupet, Joseph; Harrison, Boyd; Mazandarani, Hossein; Nawoschik, Stanley; Pangalos, Menelas N.; Ramamoorthy, Siva; Schechter, Lee; Smith, Deborah; Stack, Gary; Zhang, Jean; Zhang, Guoming; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-680</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The 5-hydroxytryptamine 2C (5-HT2C) receptor subtype has received considerable attention as a target for drug discovery, having been implicated in a wide variety of disorders.  Here, we describe the in vitro pharmacol. profile of the novel 5-HT2C receptor-selective agonist vabicaserin [(-)-4,5,6,7,9,9a,10,11,12,12a-decahydrocyclopenta[c] [1,4]diazepino[6,7,1-ij]quinoline hydrochloride] (SCA-136), including a comprehensive strategy to assess 5-HT2B receptor selectivity using diverse prepns. and assays of receptor activation.  Vabicaserin displaced 125I-(2,5-dimethoxy)phenylisopropylamine binding from human 5-HT2C receptor sites in Chinese hamster ovary cell membranes with a Ki value of 3 nM and was > 50-fold selective over a no. of serotonergic, noradrenergic, and dopaminergic receptors.  Binding affinity detd. for the human 5-HT2B receptor subtype using [3H]5HT was 14 nM.  Vabicaserin was a potent and full agonist (EC50, 8 nM; Emax, 100%) in stimulating 5-HT2C receptor-coupled calcium mobilization and exhibited 5-HT2A receptor antagonism and 5-HT2B antagonist or partial agonist activity in transfected cells, depending on the level of receptor expression.  In rat stomach fundus and human colonic longitudinal muscle endogenously expressing 5-HT2B receptors, vabicaserin failed to induce a 5-HT2B receptor-dependent contraction and produced a rightward shift of the 5-HT and α-methyl-5-HT concn.-response curves in these prepns., resp., consistent with 5-HT2B competitive antagonism.  Likewise, vabicaserin failed to induce a 5-HT2B receptor-mediated contraction in arteries from deoxycorticosterone acetate-salt-treated rats, a model of hypersensitized 5-HT2B receptor function, and produced a rightward shift in the 5-HT-induced response that was consistent with 5-HT2B receptor antagonism.  In summary, vabicaserin is a novel, potent, and selective 5-HT2C receptor agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCYu5_bxpVxbVg90H21EOLACvtfcHk0liwV_IL2Raf6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFeiur8%253D&md5=0426498cda326da150beedcebcb56aa5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.179572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.179572%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DWatts%26aufirst%3DS.%2BW.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DNawoschik%26aufirst%3DS.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DSchechter%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520vabicaserin%2520%2528SCA-136%2529%252C%2520a%2520selective%25205-hydroxytryptamine%25202C%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D337%26spage%3D673%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">WAY-163909 [(7b<i>R</i>,10a<i>R</i>)-1,2,3,4,8,9,10,10a-octahydro-7b<i>H</i>-cyclopenta-[<i>b</i>][1,4]diazepino[6,7,1-<i>hi</i> ]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1124%2Fjpet.106.106989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=17038512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=486-496&author=K.+L.+Marquisauthor=A.+L.+Sabbauthor=S.+F.+Logueauthor=J.+A.+Brennanauthor=M.+J.+Pieslaauthor=T.+A.+Comeryauthor=S.+M.+Grauerauthor=C.+R.+Ashbyauthor=H.+Q.+Nguyenauthor=L.+A.+Dawsonauthor=J.+E.+Barrettauthor=G.+Stackauthor=H.+Y.+Meltzerauthor=B.+L.+Harrisonauthor=S.+Rosenzweig-Lipson&title=WAY-163909+%5B%287bR%2C10aR%29-1%2C2%2C3%2C4%2C8%2C9%2C10%2C10a-octahydro-7bH-cyclopenta-%5Bb%5D%5B1%2C4%5Ddiazepino%5B6%2C7%2C1-hi+%5Dindole%5D%3A+A+novel+5-hydroxytryptamine+2C+receptor-selective+agonist+with+preclinical+antipsychotic-like+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span></div><div class="casAuthors">Marquis, Karen L.; Sabb, Annmarie L.; Logue, Sheree F.; Brennan, Julie A.; Piesla, Michael J.; Comery, Tom A.; Grauer, Steven M.; Ashby, Charles R., Jr.; Nguyen, Huy Q.; Dawson, Lee A.; Barrett, James E.; Stack, Gary; Meltzer, Herbert Y.; Harrison, Boyd L.; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Serotonin-2C (5-HT2C) receptor antagonists and agonists have been shown to affect dopamine (DA) neurotransmission, with agonists selectively decreasing mesolimbic DA.  As antipsychotic efficacy is proposed to be assocd. with decreased mesolimbic DA neurotransmission by virtue of DA D2 receptor antagonism, the 5-HT2C-selective receptor agonist, WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], was evaluated in animal models of schizophrenia and in vivo microdialysis and electrophysiol. to det. the effects on mesolimbic and nigrostriatal DA neurotransmission.  Similar to clozapine, WAY-163909 (1.7-30 mg/kg i.p.) decreased apomorphine-induced climbing with little effect on stereotypy and no significant induction of catalepsy.  WAY-163909 (0.3-3 mg/kg s.c.) more potently reduced phencyclidine-induced locomotor activity compared with d-amphetamine with no effect on spontaneous activity.  WAY-163909 (1.7-17 mg/kg i.p.) reversed MK-801 (5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate)- and DOI [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane]-disrupted prepulse inhibition of startle (PPI) and improved PPI in DBA/2N mice.  In conditioned avoidance responding, WAY-163909 (0.3-3 mg/kg i.p.; 1-17 mg/kg p.o.) reduced avoidance responding, an effect blocked by the 5-HT2B/2C receptor antagonist SB 206553 [5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole].  WAY-163909 (10 mg/kg s.c.) selectively decreased extracellular levels of DA in the nucleus accumbens without affecting the striatum.  Likewise, in vivo electrophysiol. recordings showed a decrease in the no. of spontaneously firing DA neurons in the ventral tegmental area but not in the substantia nigra with both acute and chronic (21-day) administration of WAY-163909 (1-10 mg/kg i.p.).  Thus, the profile of the 5-HT2C selective receptor agonist WAY-163909 is similar to that of an atypical antipsychotic and addnl. may have rapid onset properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemOaXlISXJrVg90H21EOLACvtfcHk0ljxtC0hBshtug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D&md5=f70bb5a91c306aa208b5a19cd2e21937</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106989%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DWAY-163909%2520%255B%25287bR%252C10aR%2529-1%252C2%252C3%252C4%252C8%252C9%252C10%252C10a-octahydro-7bH-cyclopenta-%255Bb%255D%255B1%252C4%255Ddiazepino%255B6%252C7%252C1-hi%2520%255Dindole%255D%253A%2520A%2520novel%25205-hydroxytryptamine%25202C%2520receptor-selective%2520agonist%2520with%2520preclinical%2520antipsychotic-like%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D486%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, P. A.</span><span> </span><span class="NLM_article-title">CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2Fj.neuropharm.2006.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=16949622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=279-290&author=J.+A.+Siuciakauthor=D.+S.+Chapinauthor=S.+A.+McCarthyauthor=V.+Guanowskyauthor=J.+Brownauthor=P.+Chiangauthor=R.+Maralaauthor=T.+Pattersonauthor=P.+A.+Seymourauthor=A.+Swickauthor=P.+A.+Iredale&title=CP-809%2C101%2C+a+selective+5-HT2C+agonist%2C+shows+activity+in+animal+models+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity</span></div><div class="casAuthors">Siuciak, Judith A.; Chapin, Douglas S.; McCarthy, Sheryl A.; Guanowsky, Victor; Brown, Janice; Chiang, Phoebe; Marala, Ravi; Patterson, Terrell; Seymour, Patricia A.; Swick, Andrew; Iredale, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-290</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CP-809,101 is a potent, functionally selective 5-HT2C agonist that displays approx. 100% efficacy in vitro.  The aim of the present studies was to assess the efficacy of a selective 5-HT2C agonist in animal models predictive of antipsychotic-like efficacy and side-effect liability.  Similar to currently available antipsychotic drugs, CP-809,101 dose-dependently inhibited conditioned avoidance responding (CAR, ED50 = 4.8 mg/kg, s.c.).  The efficacy of CP-809,101 in CAR was completely antagonized by the concurrent administration of the 5-HT2C receptor antagonist, SB-224,282.  CP-809,101 antagonized both PCP- and d-amphetamine-induced hyperactivity with ED50 values of 2.4 and 2.9 mg/kg (s.c.), resp. and also reversed an apomorphine induced-deficit in prepulse inhibition.  At doses up to 56 mg/kg, CP-809,101 did not produce catalepsy.  Thus, the present results demonstrate that the 5-HT2C agonist, CP-809,101, has a pharmacol. profile similar to that of the atypical antipsychotics with low extrapyramidal symptom liability.  CP-809,101 was inactive in two animal models of antidepressant-like activity, the forced swim test and learned helplessness.  However, CP-809,101 was active in novel object recognition, an animal model of cognitive function.  These data suggest that 5-HT2C agonists may be a novel approach in the treatment of psychosis as well as for the improvement of cognitive dysfunction assocd. with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHuHmkKSf1jrVg90H21EOLACvtfcHk0ljxtC0hBshtug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D&md5=5b422611bae3df8a9bcf71f84f1bbc37</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DMarala%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSwick%26aufirst%3DA.%26aulast%3DIredale%26aufirst%3DP.%2BA.%26atitle%3DCP-809%252C101%252C%2520a%2520selective%25205-HT2C%2520agonist%252C%2520shows%2520activity%2520in%2520animal%2520models%2520of%2520antipsychotic%2520activity%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D279%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffing, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lame, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, R. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliman, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schildknegt, K.</span><span> </span><span class="NLM_article-title">Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">848</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=848-858&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvieauthor=J.+Aubrechtauthor=E.+B.+Smithauthor=S.+L.+Coffingauthor=J.+R.+Cheungauthor=C.+Vageauthor=M.+E.+Lameauthor=P.+Chiangauthor=K.+F.+McClureauthor=T.+S.+Maurerauthor=R.+V.+Coelhoauthor=V.+F.+Solimanauthor=K.+Schildknegt&title=Genotoxicity+of+2-%283-chlorobenzyloxy%29-6-%28piperazinyl%29pyrazine%2C+a+novel+5-hydroxytryptamine2c+receptor+agonist+for+the+treatment+of+obesity%3A+role+of+metabolic+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DCoffing%26aufirst%3DS.%2BL.%26aulast%3DCheung%26aufirst%3DJ.%2BR.%26aulast%3DVage%26aufirst%3DC.%26aulast%3DLame%26aufirst%3DM.%2BE.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DSoliman%26aufirst%3DV.%2BF.%26aulast%3DSchildknegt%26aufirst%3DK.%26atitle%3DGenotoxicity%2520of%25202-%25283-chlorobenzyloxy%2529-6-%2528piperazinyl%2529pyrazine%252C%2520a%2520novel%25205-hydroxytryptamine2c%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520obesity%253A%2520role%2520of%2520metabolic%2520activation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D848%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span> </span><span class="NLM_article-title">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of <i>m</i>-chlorophenylpiperazine (mCPP)</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2F0014-2999%2894%2990690-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=8082704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1994&pages=27-38&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Involvement+of+5-HT2C+receptors+in+mediating+the+discriminative+stimulus+properties+of+m-chlorophenylpiperazine+%28mCPP%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)</span></div><div class="casAuthors">Callahan, Patrick M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-38</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats were trained to discriminate the 5-HT receptor agonist m-chlorophenylpiperazine (mCPP; 1 mg/kg) from saline using a two-lever, water-reinforced drug discrimination task.  The antidepressant trazodone (1-8 mg/kg), the 5-HT1B/2C receptor agonists 1-(m-trifluoromethylphenyl)piperazine (TFMPP; 0.25-1 mg/kg) and MK 212 (0.125-1 mg/kg), and the mixed 5-HT1A/B receptor agonist RU 24969 (0.25-2 mg/kg) substituted fully for mCPP.  The 5-HT2A/2C receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI; 0.25-1 mg/kg) and d-lysergic acid diethylamide (LSD; 0.02-0.08 mg/kg) and the 5-HT releaser fenfluramine (0.5-2 mg/kg) also mimicked mCPP.  Agonists selective for the 5-HT1A or 5-HT3 receptor or the 5-HT reuptake site produced saline-lever responding.  The ergoline deriv. mesulergine (0.5-4 mg/kg) produced a partial agonist/antagonist profile.  The 5-HT1/2 receptor antagonist metergoline (0.125-1 mg/kg) completely blocked the mCPP cue whereas the 5-HT2A/2C receptor antagonists ketanserin and LY 53857 as well as all other 5-HT receptor antagonists failed to block the mCPP cue.  The dopamine receptor antagonists SCH 23390 and haloperidol were also ineffective mCPP antagonists.  Following pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (pCPA; 100 mg/kg/day) for 3 consecutive days, the discriminability of low doses of mCPP increased, whereas the effects of fenfluramine decreased.  The present results suggest that the discriminative stimulus effects of mCPP in rats are mediated primarily by postsynaptic 5-HT2C receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebmnBj2zsK7Vg90H21EOLACvtfcHk0lg-8YFtK7y0GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D&md5=98623ad672842986facfc5cf3fa0a345</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990690-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990690-4%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DInvolvement%2520of%25205-HT2C%2520receptors%2520in%2520mediating%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520m-chlorophenylpiperazine%2520%2528mCPP%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D257%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fiorella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. C.</span><span> </span><span class="NLM_article-title">5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of <i>m</i>-chlorophenylpiperazine</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1007%2FBF02246545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=8748393" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1995&pages=237-243&author=D.+Fiorellaauthor=S.+Helsleyauthor=R.+A.+Rabinauthor=J.+C.+Winter&title=5-HT2C+receptor-mediated+phosphoinositide+turnover+and+the+stimulus+effects+of+m-chlorophenylpiperazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2FBF02246545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246545%26sid%3Dliteratum%253Aachs%26aulast%3DFiorella%26aufirst%3DD.%26aulast%3DHelsley%26aufirst%3DS.%26aulast%3DRabin%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DJ.%2BC.%26atitle%3D5-HT2C%2520receptor-mediated%2520phosphoinositide%2520turnover%2520and%2520the%2520stimulus%2520effects%2520of%2520m-chlorophenylpiperazine%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D1995%26volume%3D122%26spage%3D237%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cho, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurome, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1902</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801354e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1885-1902&author=S.+J.+Choauthor=N.+H.+Jensenauthor=T.+Kuromeauthor=S.+Kadariauthor=M.+L.+Manzanoauthor=J.+E.+Malbergauthor=B.+Caldaroneauthor=B.+L.+Rothauthor=A.+P.+Kozikowski&title=Selective+5-hydroxytryptamine+2C+receptor+agonists+derived+from+the+lead+compound+tranylcypromine%3A+identification+of+drugs+with+antidepressant-like+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm801354e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801354e%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DKurome%26aufirst%3DT.%26aulast%3DKadari%26aufirst%3DS.%26aulast%3DManzano%26aufirst%3DM.%2BL.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%25205-hydroxytryptamine%25202C%2520receptor%2520agonists%2520derived%2520from%2520the%2520lead%2520compound%2520tranylcypromine%253A%2520identification%2520of%2520drugs%2520with%2520antidepressant-like%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1885%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svennebring, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1221-1225&author=A.+P.+Kozikowskiauthor=S.+J.+Choauthor=N.+H.+Jensenauthor=J.+A.+Allenauthor=A.+M.+Svennebringauthor=B.+L.+Roth&title=HTS+and+rational+drug+design+to+generate+a+class+of+5-HT%282C%29-selective+ligands+for+possible+use+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DSvennebring%26aufirst%3DA.%2BM.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DHTS%2520and%2520rational%2520drug%2520design%2520to%2520generate%2520a%2520class%2520of%25205-HT%25282C%2529-selective%2520ligands%2520for%2520possible%2520use%2520in%2520schizophrenia%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1221%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svennebring, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200206z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=929-932&author=G.+Chenauthor=S.+J.+Choauthor=X.+P.+Huangauthor=N.+H.+Jensenauthor=A.+Svennebringauthor=M.+F.+Sassanoauthor=B.+L.+Rothauthor=A.+P.+Kozikowski&title=Rational+Drug+Design+Leading+to+the+Identification+of+a+Potent+5-HT%282C%29+Agonist+Lacking+5-HT%282B%29+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml200206z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200206z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DSvennebring%26aufirst%3DA.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520Drug%2520Design%2520Leading%2520to%2520the%2520Identification%2520of%2520a%2520Potent%25205-HT%25282C%2529%2520Agonist%2520Lacking%25205-HT%25282B%2529%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D929%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaoka, M.</span><span> </span><span class="NLM_article-title">Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=1480-1494&author=K.+Yamazakiauthor=M.+Kanaoka&title=Computational+prediction+of+the+plasma+protein-binding+percent+of+diverse+pharmaceutical+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKanaoka%26aufirst%3DM.%26atitle%3DComputational%2520prediction%2520of%2520the%2520plasma%2520protein-binding%2520percent%2520of%2520diverse%2520pharmaceutical%2520compounds%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26spage%3D1480%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span> </span><span class="NLM_article-title">Predictive in silico modeling for hERG channel blockers</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2FS1359-6446%2804%2903278-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=15718164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=149-155&author=A.+M.+Aronov&title=Predictive+in+silico+modeling+for+hERG+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive in silico modeling for hERG channel blockers</span></div><div class="casAuthors">Aronov, Alex M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-155</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  HERG-mediated sudden death as a side effect of non-antiarrhythmic drugs has been receiving increased regulatory attention.  Perhaps owing to the unique shape of the ligand-binding site and its hydrophobic character, the hERG channel has been shown to interact with pharmaceuticals of widely varying structure.  Several in silico approaches have attempted to predict hERG channel blockade.  Some of these approaches are aimed primarily at filtering out potential hERG blockers in the context of virtual libraries, others involve understanding structure-activity relationships governing hERG-drug interactions.  This review summarizes the most recent efforts in this emerging field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDgIcgWdJQJrVg90H21EOLACvtfcHk0liXApELGWxXHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbY%253D&md5=112b79a48e3d6f5ab3e313f00cf2a4fa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903278-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903278-7%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DPredictive%2520in%2520silico%2520modeling%2520for%2520hERG%2520channel%2520blockers%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D149%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Turpeinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanger, U. M.</span><span> </span><span class="NLM_article-title">Cytochrome P450 2B6: function, genetics, and clinical relevance</span> <span class="citation_source-journal">Drug Metab. Drug Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1515%2Fdmdi-2012-0027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=23152403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFWrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=185-197&author=M.+Turpeinenauthor=U.+M.+Zanger&title=Cytochrome+P450+2B6%3A+function%2C+genetics%2C+and+clinical+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 2B6: function, genetics, and clinical relevance</span></div><div class="casAuthors">Turpeinen, Miia; Zanger, Ulrich M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Drug Interactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">185-197</span>CODEN:
                <span class="NLM_cas:coden">DMDIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0792-5077</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (CYP) 2B6 belongs to the set of important hepatic drug-metabolizing CYPs.  It makes up roughly 3%-6% of total hepatic CYP content and metabolizes several pharmaceuticals including bupropion, efavirenz, cyclophosphamide, pethidine, ketamine and propofol.  The enzyme is susceptible to drug-drug interactions by enzyme induction and inhibition.  In addn. to drugs, CYP2B6 is able to both detoxify and bioactivate a no. of procarcinogens and environmental agents including pesticides and herbicides.  There is an extensive interindividual variability in the expression of CYP2B6, which is in part explained by extensive genetic polymorphism.  CYP2B6 is one of the most polymorphic CYP genes in humans with over 100 described SNPs, numerous complex haplotypes and distinct ethnic and racial frequencies.  This review summarizes the basic properties of CYP2B6 and the main characteristics of clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjYWI7Tpi-erVg90H21EOLACvtfcHk0liXApELGWxXHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFWrsbg%253D&md5=924b1c1ce4ad42a6e7f3c10255803cf7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1515%2Fdmdi-2012-0027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fdmdi-2012-0027%26sid%3Dliteratum%253Aachs%26aulast%3DTurpeinen%26aufirst%3DM.%26aulast%3DZanger%26aufirst%3DU.%2BM.%26atitle%3DCytochrome%2520P450%25202B6%253A%2520function%252C%2520genetics%252C%2520and%2520clinical%2520relevance%26jtitle%3DDrug%2520Metab.%2520Drug%2520Interact.%26date%3D2012%26volume%3D27%26spage%3D185%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span> </span><span class="NLM_article-title">Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=953-955&author=M.+J.+Millanauthor=A.+Dekeyneauthor=A.+Gobert&title=Serotonin+%285-HT%292C+receptors+tonically+inhibit+dopamine+%28DA%29+and+noradrenaline+%28NA%29%2C+but+not+5-HT%2C+release+in+the+frontal+cortex+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DSerotonin%2520%25285-HT%25292C%2520receptors%2520tonically%2520inhibit%2520dopamine%2520%2528DA%2529%2520and%2520noradrenaline%2520%2528NA%2529%252C%2520but%2520not%25205-HT%252C%2520release%2520in%2520the%2520frontal%2520cortex%2520in%2520vivo%26jtitle%3DNeuropharmacology%26date%3D1998%26volume%3D37%26spage%3D953%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Di Giovanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Matteo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Mascio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span> </span><span class="NLM_article-title">Preferential modulation of mesolimbic vs nigrostriatal dopaminergic function by serotonin (2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=53-61&author=G.+Di+Giovanniauthor=V.+Di+Matteoauthor=M.+Di+Mascioauthor=E.+Esposito&title=Preferential+modulation+of+mesolimbic+vs+nigrostriatal+dopaminergic+function+by+serotonin+%282C%2F2B%29+receptor+agonists%3A+a+combined+in+vivo+electrophysiological+and+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiovanni%26aufirst%3DG.%26aulast%3DDi%2BMatteo%26aufirst%3DV.%26aulast%3DDi%2BMascio%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DE.%26atitle%3DPreferential%2520modulation%2520of%2520mesolimbic%2520vs%2520nigrostriatal%2520dopaminergic%2520function%2520by%2520serotonin%2520%25282C%252F2B%2529%2520receptor%2520agonists%253A%2520a%2520combined%2520in%2520vivo%2520electrophysiological%2520and%2520microdialysis%2520study%26jtitle%3DSynapse%26date%3D2000%26volume%3D35%26spage%3D53%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">5-HT2 receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.2174%2F1568007043482598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=14965241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=11-26&author=J.+E.+Leysen&title=5-HT2+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2 receptors</span></div><div class="casAuthors">Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT2 receptors are G-protein coupled receptors that currently comprise 3 subtypes: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  The subtypes are related in their mol. structure, amino acid sequence, and signaling properties.  5-HT2A and 5-HT2C receptors have a widespread distribution and function in the central nervous system.  5-HT2A and 5-HT2C receptor antagonism is a property of certain antipsychotic and antidepressant drugs.  5-HT2B receptors have a restricted expression in the central nervous system.  They have an important role in embryogenesis and in the periphery.  In this article, selected aspects of 5-HT2 receptor research are reviewed for each subtype under 3 main headings: (1) genes, protein structure, and receptor signaling; (2) receptor localization with emphasis on the CNS, and (3) compds.  The general discussion reflects on the reasons for the limited success in the clinic of 5-HT2 receptor subtype selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGTjJwjn8erVg90H21EOLACvtfcHk0liXApELGWxXHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D&md5=9f7316c92e674a8c1cf7b13f48d9711a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F1568007043482598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482598%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3D5-HT2%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural features for functional selectivity at serotonin receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1126%2Fscience.1232808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=23519215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=615-619&author=D.+Wackerauthor=C.+Wangauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=E.+Vardyauthor=J.+D.+McCorvyauthor=Y.+Jiangauthor=M.+Chuauthor=F.+Y.+Siuauthor=W.+Liuauthor=H.+E.+Xuauthor=V.+Cherezovauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+features+for+functional+selectivity+at+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features for Functional Selectivity at Serotonin Receptors</span></div><div class="casAuthors">Wacker, Daniel; Wang, Chong; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Jiang, Yi; Chu, Meihua; Siu, Fai Yiu; Liu, Wei; Xu, H. Eric; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">615-619</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Drugs active at G protein-coupled receptors (GPCRs) can differentially modulate either canonical or noncanonical signaling pathways via a phenomenon known as functional selectivity or biased signaling.  The authors report biochem. studies showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ERG), and related ergolines display strong functional selectivity for β-arrestin signaling at the 5-HT2B 5-hydroxytryptamine (5-HT) receptor, whereas they are relatively unbiased at the 5-HT1B receptor.  To investigate the structural basis for biased signaling, the authors detd. the crystal structure of the human 5-HT2B receptor bound to ERG and compared it with the 5-HT1B/ERG structure.  Given the relatively poor understanding of GPCR structure and function to date, insight into different GPCR signaling pathways is important to better understand both adverse and favorable therapeutic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreo_QegM-j7bVg90H21EOLACvtfcHk0lh7SDRIcKMlQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D&md5=16e96d0255be3ac367aeda7187aa4c15</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232808%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520features%2520for%2520functional%2520selectivity%2520at%2520serotonin%2520receptors%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D615%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Marti-Renom, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sali, A.</span><span> </span><span class="NLM_article-title">Comparative protein structure modeling of genes and genomes</span> <span class="citation_source-journal">Annu. Rev. Biophys. Biomol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1146%2Fannurev.biophys.29.1.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=10940251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=291-325&author=M.+A.+Marti-Renomauthor=A.+C.+Stuartauthor=A.+Fiserauthor=R.+Sanchezauthor=F.+Meloauthor=A.+Sali&title=Comparative+protein+structure+modeling+of+genes+and+genomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein structure modeling of genes and genomes</span></div><div class="casAuthors">Marti-Renom, Marc A.; Stuart, Ashley C.; Fiser, Andras; Sanchez, Roberto; Melo, Francisco; Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Biomolecular Structure</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-325</span>CODEN:
                <span class="NLM_cas:coden">ABBSE4</span>;
        ISSN:<span class="NLM_cas:issn">1056-8700</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 212 refs.  Comparative modeling predicts the three-dimensional structure of a given protein sequence (target) based primarily on its alignment to one or more proteins of known structure (templates).  The prediction process consists of fold assignment, target-template alignment, model building, and model evaluation.  The no. of protein sequences that can be modeled and the accuracy of the predictions are increasing steadily because of the growth in the no. of known protein structures and because of the improvements in the modeling software.  Further advances are necessary in recognizing weak sequence-structure similarities, aligning sequences with structures, modeling of rigid body shifts, distortions, loops and side chains, as well as detecting errors in a model.  Despite these problems, it is currently possible to model with useful accuracy significant parts of approx. one third of all known protein sequences.  The use of individual comparative models in biol. is already rewarding and increasingly widespread.  A major new challenge for comparative modeling is the integration of it with the torrents of data from genome sequencing projects as well as from functional and structural genomics.  In particular, there is a need to develop an automated, rapid, robust, sensitive, and accurate comparative modeling pipeline applicable to whole genomes.  Such large-scale modeling is likely to encourage new kinds of applications for the many resulting models, based on their large no. and completeness at the level of the family, organism, or functional network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq45B6Amw-zi7Vg90H21EOLACvtfcHk0lh7SDRIcKMlQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D&md5=d97ffe6c47c4a3bae2bbbf14c045afdd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biophys.29.1.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biophys.29.1.291%26sid%3Dliteratum%253Aachs%26aulast%3DMarti-Renom%26aufirst%3DM.%2BA.%26aulast%3DStuart%26aufirst%3DA.%2BC.%26aulast%3DFiser%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DMelo%26aufirst%3DF.%26aulast%3DSali%26aufirst%3DA.%26atitle%3DComparative%2520protein%2520structure%2520modeling%2520of%2520genes%2520and%2520genomes%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D2000%26volume%3D29%26spage%3D291%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Korb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutzle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span><span> </span><span class="NLM_article-title">Empirical scoring functions for advanced protein-ligand docking with PLANTS</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci800298z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=84-96&author=O.+Korbauthor=T.+Stutzleauthor=T.+E.+Exner&title=Empirical+scoring+functions+for+advanced+protein-ligand+docking+with+PLANTS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS</span></div><div class="casAuthors">Korb, Oliver; Stuetzle, Thomas; Exner, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-96</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper we present two empirical scoring functions, PLANTSCHEMPLP and PLANTSPLP, designed for our docking algorithm PLANTS (Protein-Ligand ANT System), which is based on ant colony optimization (ACO).  They are related, regarding their functional form, to parts of already published scoring functions and force fields.  The parametrization procedure described here was able to identify several parameter settings showing an excellent performance for the task of pose prediction on two test sets comprising 298 complexes in total.  Up to 87% of the complexes of the Astex diverse set and 77% of the CCDC/Astex clean listnc (noncovalently bound complexes of the clean list) could be reproduced with root-mean-square deviations of less than 2 Å with respect to the exptl. detd. structures.  A comparison with the state-of-the-art docking tool GOLD clearly shows that this is, esp. for the druglike Astex diverse set, an improvement in pose prediction performance.  Addnl., optimized parameter settings for the search algorithm were identified, which can be used to balance pose prediction reliability and search speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_kyR7CGk9mbVg90H21EOLACvtfcHk0lh7SDRIcKMlQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D&md5=fce960b75b9f8906354b7c97ff84c092</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fci800298z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800298z%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DStutzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DEmpirical%2520scoring%2520functions%2520for%2520advanced%2520protein-ligand%2520docking%2520with%2520PLANTS%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D84%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Qingtong Zhou, Wenzhong Yan, Jian Sun, Alan P. Kozikowski, Suwen Zhao, Xi-Ping Huang, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4579-4602. <a href="https://doi.org/10.1021/acs.jmedchem.9b01835" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01835%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBitopic%252B2-Phenylcyclopropylmethylamine%252B%252528PCPMA%252529%252BDerivatives%252Bas%252BSelective%252BDopamine%252BD3%252BReceptor%252BLigands%26aulast%3DTan%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18112019%26date%3D23042020%26date%3D13042020%26volume%3D63%26issue%3D9%26spage%3D4579%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiabin Ni, Bekzod Nishonov, Azizbek Pardaev, <span class="NLM_string-name hlFld-ContribAuthor">Ao Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Ring-Opening Coupling of gem-Difluorocyclopropanes for the Construction of 2-Fluoroallylic Sulfones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (21)
                                     , 13646-13654. <a href="https://doi.org/10.1021/acs.joc.9b01897" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01897</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01897%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-Catalyzed%252BRing-Opening%252BCoupling%252Bof%252Bgem-Difluorocyclopropanes%252Bfor%252Bthe%252BConstruction%252Bof%252B2-Fluoroallylic%252BSulfones%26aulast%3DNi%26aufirst%3DJiabin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12072019%26date%3D03102019%26date%3D20092019%26volume%3D84%26issue%3D21%26spage%3D13646%26epage%3D13654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Paul J.  Lorello</span>, <span class="hlFld-ContribAuthor ">Barbara J.  Caldarone</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6273-6288. <a href="https://doi.org/10.1021/acs.jmedchem.7b00584" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00584%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-Substituted%252B%2525282-Phenylcyclopropyl%252529methylamines%252Bas%252BFunctionally%252BSelective%252BSerotonin%252B2C%252BReceptor%252BAgonists%252Bfor%252BPotential%252BUse%252Bas%252BAntipsychotic%252BMedications%26aulast%3DZhang%26aufirst%3DGuiping%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17042017%26date%3D18072017%26date%3D27072017%26date%3D28062017%26volume%3D60%26issue%3D14%26spage%3D6273%26epage%3D6288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juhyeon  Kim</span>, <span class="hlFld-ContribAuthor ">Byung Seok  Moon</span>, <span class="hlFld-ContribAuthor ">Byung Chul  Lee</span>, <span class="hlFld-ContribAuthor ">Ho-Young  Lee</span>, <span class="hlFld-ContribAuthor ">Hak-Joong  Kim</span>, <span class="hlFld-ContribAuthor ">Hyunah  Choo</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Yong Seo  Cho</span>, and <span class="hlFld-ContribAuthor ">Sun-Joon  Min</span>  . </span><span class="cited-content_cbyCitation_article-title">A Potential PET Radiotracer for the 5-HT2C Receptor: Synthesis and in Vivo Evaluation of 4-(3-[18F]fluorophenethoxy)pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (5)
                                     , 996-1003. <a href="https://doi.org/10.1021/acschemneuro.6b00445" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00445%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BPotential%252BPET%252BRadiotracer%252Bfor%252Bthe%252B5-HT2C%252BReceptor%25253A%252BSynthesis%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252B4-%2525283-%25255B18F%25255Dfluorophenethoxy%252529pyrimidine%26aulast%3DKim%26aufirst%3DJuhyeon%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20122016%26date%3D14022017%26date%3D27022017%26date%3D17052017%26date%3D14022017%26volume%3D8%26issue%3D5%26spage%3D996%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Giguere</span>, <span class="hlFld-ContribAuthor ">Hu  Zhu</span>, <span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9866-9880. <a href="https://doi.org/10.1021/acs.jmedchem.6b01194" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01194%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BDiscovery%252Bof%252BFunctionally%252BSelective%252BSerotonin%252B2C%252B%2525285-HT2C%252529%252BReceptor%252BAgonists%26aulast%3DCheng%26aufirst%3DJianjun%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D10082016%26date%3D25102016%26date%3D10112016%26date%3D11102016%26volume%3D59%26issue%3D21%26spage%3D9866%26epage%3D9880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Lv</span>, <span class="hlFld-ContribAuthor ">Brian  Budke</span>, <span class="hlFld-ContribAuthor ">Michal  Pawlowski</span>, <span class="hlFld-ContribAuthor ">Philip P.  Connell</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4511-4525. <a href="https://doi.org/10.1021/acs.jmedchem.5b01762" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BSmall%252BMolecules%252Bthat%252BSpecifically%252BInhibit%252Bthe%252BD-loop%252BActivity%252Bof%252BRAD51%26aulast%3DLv%26aufirst%3DWei%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D11112015%26date%3D21042016%26date%3D26052016%26date%3D06042016%26volume%3D59%26issue%3D10%26spage%3D4511%26epage%3D4525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Giguere</span>, <span class="hlFld-ContribAuthor ">Claire M.  Schmerberg</span>, <span class="hlFld-ContribAuthor ">Vladimir M.  Pogorelov</span>, <span class="hlFld-ContribAuthor ">Ramona M.  Rodriguiz</span>, <span class="hlFld-ContribAuthor ">Xi-Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Hu  Zhu</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">William C.  Wetsel</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 578-591. <a href="https://doi.org/10.1021/acs.jmedchem.5b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFurther%252BAdvances%252Bin%252BOptimizing%252B%2525282-Phenylcyclopropyl%252529methylamines%252Bas%252BNovel%252BSerotonin%252B2C%252BAgonists%25253A%252BEffects%252Bon%252BHyperlocomotion%25252C%252BPrepulse%252BInhibition%25252C%252Band%252BCognition%252BModels%26aulast%3DCheng%26aufirst%3DJianjun%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D22072015%26date%3D13012016%26date%3D28012016%26date%3D24122015%26volume%3D59%26issue%3D2%26spage%3D578%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohui  Geng</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Huibin  Wang</span>, <span class="hlFld-ContribAuthor ">Baichun  Hu</span>, <span class="hlFld-ContribAuthor ">Junhao  Huang</span>, <span class="hlFld-ContribAuthor ">Yiheng  Wu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Fengjiao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              strategy for isoform-selective 5-HT
              2A
              R and 5-HT
              2C
              R inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Systems Design & Engineering</span><span> <strong>2021,</strong> <em>6 </em>
                                    (2)
                                     , 139-155. <a href="https://doi.org/10.1039/D0ME00137F" title="DOI URL">https://doi.org/10.1039/D0ME00137F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0ME00137F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0ME00137F%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Systems%2520Design%2520%2526%2520Engineering%26atitle%3DIn%252Bsilico%252Bstrategy%252Bfor%252Bisoform-selective%252B5-HT%252B2A%252BR%252Band%252B5-HT%252B2C%252BR%252Binhibitors%26aulast%3DGeng%26aufirst%3DXiaohui%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D2%26spage%3D139%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guy A.  Higgins</span>, <span class="hlFld-ContribAuthor ">Paul J.  Fletcher</span>, <span class="hlFld-ContribAuthor ">William R.  Shanahan</span>. </span><span class="cited-content_cbyCitation_article-title">Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>205 </em>, 107417. <a href="https://doi.org/10.1016/j.pharmthera.2019.107417" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.107417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.107417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.107417%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DLorcaserin%25253A%252BA%252Breview%252Bof%252Bits%252Bpreclinical%252Band%252Bclinical%252Bpharmacology%252Band%252Btherapeutic%252Bpotential%26aulast%3DHiggins%26aufirst%3DGuy%2BA.%26date%3D2020%26volume%3D205%26spage%3D107417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiping  Zhang</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Sida  Shen</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111626. <a href="https://doi.org/10.1016/j.ejmech.2019.111626" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111626%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Bfluorinated%252Bcyclopropane%252Bderivatives%252Bof%252B2-phenylcyclopropylmethylamine%252Bleading%252Bto%252Bidentification%252Bof%252Ba%252Bselective%252Bserotonin%252B2C%252B%2525285-HT2C%252529%252Breceptor%252Bagonist%252Bwithout%252B5-HT2B%252Bagonism%26aulast%3DZhang%26aufirst%3DGuiping%26date%3D2019%26volume%3D182%26spage%3D111626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric A.  Wold</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Wild</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (16)
                                     , 1381-1398. <a href="https://doi.org/10.2174/1568026619666190709101449" title="DOI URL">https://doi.org/10.2174/1568026619666190709101449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190709101449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190709101449%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252B5-HT2C%252BReceptor%252Bin%252BBiological%252BContext%252Band%252Bthe%252BCurrent%252BState%252Bof%252B5-HT2C%252BReceptor%252BLigand%252BDevelopment%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2019%26volume%3D19%26issue%3D16%26spage%3D1381%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan-qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-wei  Lin</span>, <span class="hlFld-ContribAuthor ">Nan  Wu</span>, <span class="hlFld-ContribAuthor ">Si-yi  Wang</span>, <span class="hlFld-ContribAuthor ">Mao-zi  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-hua  Lin</span>, <span class="hlFld-ContribAuthor ">Xiang-Qun  Xie</span>, <span class="hlFld-ContribAuthor ">Zhi-wei  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2019,</strong> <em>40 </em>
                                    (9)
                                     , 1138-1156. <a href="https://doi.org/10.1038/s41401-019-0217-9" title="DOI URL">https://doi.org/10.1038/s41401-019-0217-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0217-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0217-9%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DStructural%252Binsight%252Binto%252Bthe%252Bserotonin%252B%2525285-HT%252529%252Breceptor%252Bfamily%252Bby%252Bmolecular%252Bdocking%25252C%252Bmolecular%252Bdynamics%252Bsimulation%252Band%252Bsystems%252Bpharmacology%252Banalysis%26aulast%3DWang%26aufirst%3DYuan-qiang%26date%3D2019%26date%3D2019%26volume%3D40%26issue%3D9%26spage%3D1138%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juhyeon  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon Jung  Kim</span>, <span class="hlFld-ContribAuthor ">Ashwini M.  Londhe</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Hyunah  Choo</span>, <span class="hlFld-ContribAuthor ">Hak Joong  Kim</span>, <span class="hlFld-ContribAuthor ">Sun-Joon  Min</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT2C Agonists. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (18)
                                     , 3234. <a href="https://doi.org/10.3390/molecules24183234" title="DOI URL">https://doi.org/10.3390/molecules24183234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24183234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24183234%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BDisubstituted%252BPyrimidines%252Bas%252BSelective%252B5-HT2C%252BAgonists%26aulast%3DKim%26aufirst%3DJuhyeon%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D18%26spage%3D3234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myriam  Drouin</span>, <span class="hlFld-ContribAuthor ">Jean-François  Paquin</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective palladium-catalyzed addition of malonates to 3,3-difluoropropenes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (41)
                                     , 6023-6032. <a href="https://doi.org/10.1016/j.tet.2018.08.034" title="DOI URL">https://doi.org/10.1016/j.tet.2018.08.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.08.034%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DEnantioselective%252Bpalladium-catalyzed%252Baddition%252Bof%252Bmalonates%252Bto%252B3%25252C3-difluoropropenes%26aulast%3DDrouin%26aufirst%3DMyriam%26date%3D2018%26volume%3D74%26issue%3D41%26spage%3D6023%26epage%3D6032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan‐Ru  Yeh</span>, <span class="hlFld-ContribAuthor ">Yi‐Jia  Tzeng</span>, <span class="hlFld-ContribAuthor ">Shau‐Wei  Tsai</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Improvements and Insights into CALB‐Catalyzed Resolution of
              trans
              ‐ and
              cis
              ‐2‐Phenylcyclopropyl Azolides. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (19)
                                     , 5353-5360. <a href="https://doi.org/10.1002/slct.201800578" title="DOI URL">https://doi.org/10.1002/slct.201800578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201800578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201800578%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DQuantitative%252BImprovements%252Band%252BInsights%252Binto%252BCALB%2525E2%252580%252590Catalyzed%252BResolution%252Bof%252Btrans%252B%2525E2%252580%252590%252Band%252Bcis%252B%2525E2%252580%2525902%2525E2%252580%252590Phenylcyclopropyl%252BAzolides%26aulast%3DYeh%26aufirst%3DYan%25E2%2580%2590Ru%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D19%26spage%3D5353%26epage%3D5360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir M  Pogorelov</span>, <span class="hlFld-ContribAuthor ">Ramona M  Rodriguiz</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Mei  Huang</span>, <span class="hlFld-ContribAuthor ">Claire M  Schmerberg</span>, <span class="hlFld-ContribAuthor ">Herbert Y  Meltzer</span>, <span class="hlFld-ContribAuthor ">Bryan L  Roth</span>, <span class="hlFld-ContribAuthor ">Alan P  Kozikowski</span>, <span class="hlFld-ContribAuthor ">William C  Wetsel</span>. </span><span class="cited-content_cbyCitation_article-title">5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2017,</strong> <em>42 </em>
                                    (11)
                                     , 2163-2177. <a href="https://doi.org/10.1038/npp.2017.52" title="DOI URL">https://doi.org/10.1038/npp.2017.52</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/npp.2017.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnpp.2017.52%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3D5-HT2C%252BAgonists%252BModulate%252BSchizophrenia-Like%252BBehaviors%252Bin%252BMice%26aulast%3DPogorelov%26aufirst%3DVladimir%2BM%26date%3D2017%26date%3D2017%26volume%3D42%26issue%3D11%26spage%3D2163%26epage%3D2177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Congreve</span>, <span class="hlFld-ContribAuthor ">A.  Bortolato</span>, <span class="hlFld-ContribAuthor ">G.  Brown</span>, <span class="hlFld-ContribAuthor ">R.M.  Cooke</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling and Design for Membrane Protein Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 145-188. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12358-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12358-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12358-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12358-3%26sid%3Dliteratum%253Aachs%26atitle%3DModeling%252Band%252BDesign%252Bfor%252BMembrane%252BProtein%252BTargets%26aulast%3DCongreve%26aufirst%3DM.%26date%3D2017%26spage%3D145%26epage%3D188%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Mario  Giannella</span>, <span class="hlFld-ContribAuthor ">Gianfabio  Giorgioni</span>, <span class="hlFld-ContribAuthor ">Alessandro  Piergentili</span>, <span class="hlFld-ContribAuthor ">Riccardo  Petrelli</span>, <span class="hlFld-ContribAuthor ">Carlo  Cifani</span>, <span class="hlFld-ContribAuthor ">Maria Vittoria  Micioni Di Bonaventura</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Keck</span>, <span class="hlFld-ContribAuthor ">Angelica  Mazzolari</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Elena  Poggesi</span>, <span class="hlFld-ContribAuthor ">Rosanna  Matucci</span>, <span class="hlFld-ContribAuthor ">Wilma  Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 233-244. <a href="https://doi.org/10.1016/j.ejmech.2016.09.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Breplacement%252Bof%252Bthe%252B2-methoxy%252Bsubstituent%252Bof%252BN-%252528%2525286%25252C6-diphenyl-1%25252C4-dioxan-2-yl%252529methyl%252529-2-%2525282-methoxyphenoxy%252529ethan-1-amine%252Bimproves%252Bthe%252Bselectivity%252Bfor%252B5-HT1A%252Breceptor%252Bover%252B%2525CE%2525B11-adrenoceptor%252Band%2525C2%2525A0D2-like%252Breceptor%252Bsubtypes%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2017%26volume%3D125%26spage%3D233%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myriam  Drouin</span>, <span class="hlFld-ContribAuthor ">Sébastien  Tremblay</span>, <span class="hlFld-ContribAuthor ">Jean-François  Paquin</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed synthesis of monofluoroalkenes from 3,3-difluoropropenes using dimethylmalonate and derivatives as nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (11)
                                     , 2376-2384. <a href="https://doi.org/10.1039/C7OB00376E" title="DOI URL">https://doi.org/10.1039/C7OB00376E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00376E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00376E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPalladium-catalyzed%252Bsynthesis%252Bof%252Bmonofluoroalkenes%252Bfrom%252B3%25252C3-difluoropropenes%252Busing%252Bdimethylmalonate%252Band%252Bderivatives%252Bas%252Bnucleophiles%26aulast%3DDrouin%26aufirst%3DMyriam%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D11%26spage%3D2376%26epage%3D2384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Di Giovanni</span>, <span class="hlFld-ContribAuthor ">Philippe  De Deurwaerdère</span>. </span><span class="cited-content_cbyCitation_article-title">New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2016,</strong> <em>157 </em>, 125-162. <a href="https://doi.org/10.1016/j.pharmthera.2015.11.009" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.11.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.11.009%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DNew%252Btherapeutic%252Bopportunities%252Bfor%252B5-HT2C%252Breceptor%252Bligands%252Bin%252Bneuropsychiatric%252Bdisorders%26aulast%3DDi%2BGiovanni%26aufirst%3DGiuseppe%26date%3D2016%26volume%3D157%26spage%3D125%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">We Need 2C but Not 2B: Developing Serotonin 2C (5-HT
              2C
              ) Receptor Agonists for the Treatment of CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , 1963-1967. <a href="https://doi.org/10.1002/cmdc.201500437" title="DOI URL">https://doi.org/10.1002/cmdc.201500437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500437%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DWe%252BNeed%252B2C%252Bbut%252BNot%252B2B%25253A%252BDeveloping%252BSerotonin%252B2C%252B%2525285-HT%252B2C%252B%252529%252BReceptor%252BAgonists%252Bfor%252Bthe%252BTreatment%252Bof%252BCNS%252BDisorders%26aulast%3DCheng%26aufirst%3DJianjun%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D1963%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Lawson</span>, <span class="hlFld-ContribAuthor ">Jérôme  Bignon</span>, <span class="hlFld-ContribAuthor ">Jean-Daniel  Brion</span>, <span class="hlFld-ContribAuthor ">Abdallah  Hamze</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free Synthesis of Polysubstituted Cyclopropane Derivatives from
              N
              -Tosylhydrazones and their Cytotoxic Activities. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>4 </em>
                                    (10)
                                     , 1144-1154. <a href="https://doi.org/10.1002/ajoc.201500289" title="DOI URL">https://doi.org/10.1002/ajoc.201500289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201500289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201500289%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTransition-Metal-Free%252BSynthesis%252Bof%252BPolysubstituted%252BCyclopropane%252BDerivatives%252Bfrom%252BN%252B-Tosylhydrazones%252Band%252Btheir%252BCytotoxic%252BActivities%26aulast%3DLawson%26aufirst%3DMarie%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D10%26spage%3D1144%26epage%3D1154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio N.  Cavasotto</span>, <span class="hlFld-ContribAuthor ">Damián  Palomba</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2015,</strong> <em>51 </em>
                                    (71)
                                     , 13576-13594. <a href="https://doi.org/10.1039/C5CC05050B" title="DOI URL">https://doi.org/10.1039/C5CC05050B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC05050B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC05050B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DExpanding%252Bthe%252Bhorizons%252Bof%252BG%252Bprotein-coupled%252Breceptor%252Bstructure-based%252Bligand%252Bdiscovery%252Band%252Boptimization%252Busing%252Bhomology%252Bmodels%26aulast%3DCavasotto%26aufirst%3DClaudio%2BN.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D71%26spage%3D13576%26epage%3D13594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative 5-HT<sub>2C</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selective 5-HT<sub>2C</sub> agonists based on 2-phenylcyclopropylmethylamine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 5-Chloro Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Williamson ether synthesis with R<sup>1</sup>X or Mitsunobu reaction with appropriate alcohols; (b) chiral prep-HPLC separation; (c) <b>13c</b>, <b>13d</b>, <b>13f</b>, <b>13h</b>, and <b>13i</b>, TFA/CH<sub>2</sub>Cl<sub>2</sub>, rt, 1h; <b>13a</b>, <b>13b</b>, <b>13e</b>, <b>13g</b>, <b>13j</b>–<b>13n</b>, 2 M HCl in diethyl ether, rt, 24–48 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5-Fluoro Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Williamson ether synthesis with R<sup>1</sup>X or Mitsunobu reaction with appropriate alcohols; (b) chiral prep-HPLC separation; (c) 2 M HCl in diethyl ether, rt, 24 h, 64–80%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cumulative locomotor activity following injection of the vehicle (Veh) or 3 mg/kg <span class="smallcaps smallerCapital">d</span>-amphetamine (AMPH). AMPH-stimulated locomotor activity in the Veh–AMPH group was higher than that in all other groups tested. Locomotion in the Veh–Veh group was similar to that in the (+)-<b>13j</b>–Veh, (+)-<b>13l</b>–Veh, (+)-<b>16b</b>–Veh, and (+)-<b>16d</b>–Veh groups (i.e., 20-Veh groups). Both 10 and 20 mg/kg of each of the four compounds decreased the AMPH-stimulated hyperlocomotion, with 20 mg/kg (+)-<b>13j</b> and (+)-<b>16b</b> being the most efficacious. <i>N</i> = 8–16 mice/group; *, <i>p</i> < 0.035, from the Veh–AMPH group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Predicted binding poses of compound (+)-<b>16b</b> in 5-HT<sub>2C</sub>. (a) Docking poses of compound (+)-<b>16b</b> in the 7-transmembrane domain (7TMD) of the 5-HT<sub>2C_inactive</sub> (compound shown in light yellow, protein shown in gray) and 5-HT<sub>2C_active</sub> (compound shown in orange, protein shown in green) conformations. (b) Magnified view of binding sites of compound (+)-<b>16b</b> in 5-HT<sub>2C_inactive</sub>. (c) Magnified view of binding sites of compound (+)-<b>16b</b> in 5-HT<sub>2C_active</sub>. (d) Overlay of compound (+)-<b>16b</b> (orange) with (+)-<b>13h</b> (sky blue) in the binding pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/medium/jm-2014-019274_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Overlay of compound (+)-<b>16b</b> (orange) with lorcaserin (pink) in the binding pocket of 5-HT<sub>2C_active</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5019274/20150220/images/large/jm-2014-019274_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019274&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The expanded biology of serotonin</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1146%2Fannurev.med.60.042307.110802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=19630576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=355-366&author=M.+Bergerauthor=J.+A.+Grayauthor=B.+L.+Roth&title=The+expanded+biology+of+serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The expanded biology of serotonin</span></div><div class="casAuthors">Berger, Miles; Gray, John A.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-366</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin is perhaps best known as a neurotransmitter that modulates neural activity and a wide range of neuropsychol. processes, and drugs that target serotonin receptors are used widely in psychiatry and neurol.  However, most serotonin is found outside the central nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as within the brain.  Serotonin regulates numerous biol. processes including cardiovascular function, bowel motility, ejaculatory latency, and bladder control.  Addnl., new work suggests that serotonin may regulate some processes, including platelet aggregation, by receptor-independent, transglutaminase-dependent covalent linkage to cellular proteins.  We review this new expanded serotonin biol. and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoz0HW5hdNOrVg90H21EOLACvtfcHk0lgldC6bdtMuBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D&md5=0557e01e6b79dbfb50559aca03f8b31f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.60.042307.110802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.60.042307.110802%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520expanded%2520biology%2520of%2520serotonin%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2009%26volume%3D60%26spage%3D355%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. D.</span><span> </span><span class="NLM_article-title">Serotonin receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr078224o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1614-1641&author=D.+E.+Nicholsauthor=C.+D.+Nichols&title=Serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin Receptors</span></div><div class="casAuthors">Nichols, David E.; Nichols, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1614-1641</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on phylogeny, structural features, oligomerization, classification and functions of serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnlR5CHbuX7Vg90H21EOLACvtfcHk0lgldC6bdtMuBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslOisL8%253D&md5=55b70829f6be71cbfe4de05c5ef665d8</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fcr078224o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr078224o%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DNichols%26aufirst%3DC.%2BD.%26atitle%3DSerotonin%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D1614%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4986-4991&author=H.+Y.+Meltzerauthor=B.+L.+Roth&title=Lorcaserin+and+pimavanserin%3A+emerging+selectivity+of+serotonin+receptor+subtype-targeted+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DLorcaserin%2520and%2520pimavanserin%253A%2520emerging%2520selectivity%2520of%2520serotonin%2520receptor%2520subtype-targeted%2520drugs%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4986%26epage%3D4991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Smith, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span> </span><span class="NLM_article-title">The potential use of selective 5-HT2C agonists in treating obesity</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1517%2F13543784.15.3.257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=16503763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVKns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=257-266&author=B.+M.+Smithauthor=W.+J.+Thomsenauthor=A.+J.+Grottick&title=The+potential+use+of+selective+5-HT2C+agonists+in+treating+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The potential use of selective 5-HT2C agonists in treating obesity</span></div><div class="casAuthors">Smith, Brian M.; Thomsen, William J.; Grottick, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-266</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Activation of central 5-HT2C receptors as a strategy for appetite suppression and wt. control is supported by animal pharmacol. and human clin. studies.  Considerable evidence comes from the wt.-loss effects of fenfluramine, a non-selective 5-HT2C agonist.  Advances in mol. pharmacol. have led to an understanding of the effects of 5-HT2C receptor activation on food intake and satiety, in addn. to providing insight into the causes of cardiac valvular insufficiency and pulmonary hypertension assocd. with the use of fenfluramine.  However, clin. validated animal models of drug-induced disease and knowledge of the mol. mechanisms of these safety issues is lacking.  For this reason, the development of selective 5-HT2C agonists for the treatment of obesity has remained a challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq33JUfMDIf8LVg90H21EOLACvtfcHk0lju-552FMZ3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVKns7s%253D&md5=902b389c885f6b321e7baf69ebcfdfcb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543784.15.3.257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.15.3.257%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BM.%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520potential%2520use%2520of%2520selective%25205-HT2C%2520agonists%2520in%2520treating%2520obesity%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D15%26spage%3D257%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sargent, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, A. J.</span><span> </span><span class="NLM_article-title">Targeting 5-HT receptors for the treatment of obesity</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2Fj.coph.2011.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=21330209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=52-58&author=B.+J.+Sargentauthor=A.+J.+Henderson&title=Targeting+5-HT+receptors+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting 5-HT receptors for the treatment of obesity</span></div><div class="casAuthors">Sargent, Bruce J.; Henderson, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is known to have anorectic properties through centrally acting mechanisms.  Three serotonin receptors have been implicated in mediating these effects: 5-HT1B, 5-HT2C and 5-HT6.  Hypophagic effects are elicited through agonism of the former two receptors, whereas antagonism of the 5-HT6 receptor appears to have an anorectic effect.  All three targets have been validated through extensive studies including knockout mice and selective ligand assessment.  5-HT1B receptor agonists have limited utility due to mechanism-based side effects, whereas 5-HT2C receptor agonists suffer from challenges assocd. with selectivity over the closely related 5-HT2A and 5-HT2B receptors.  5-HT6 receptor antagonists appear to offer great promise, although the mechanisms through which they reduce food intake and body wt. are not fully understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7HpGhwkLC1LVg90H21EOLACvtfcHk0lju-552FMZ3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs70%253D&md5=6f7344a29e985af4a08d76626dc6d8f9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DHenderson%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%25205-HT%2520receptors%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D52%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span> </span><span class="NLM_article-title">5-HT(2C) agonists as therapeutics for the treatment of schizophrenia</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1007%2F978-3-642-25758-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=23027415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=147-165&author=S.+Rosenzweig-Lipsonauthor=T.+A.+Comeryauthor=K.+L.+Marquisauthor=J.+Grossauthor=J.+Dunlop&title=5-HT%282C%29+agonists+as+therapeutics+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C agonists as therapeutics for the treatment of schizophrenia</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Comery, Thomas A.; Marquis, Karen L.; Gross, Jonathan; Dunlop, John</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">147-165</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The 5-HT2C receptor is a highly complex, highly regulated receptor which is widely distributed throughout the brain.  The 5-HT2C receptor couples to multiple signal transduction pathways leading to engagement of a no. of intracellular signaling mols.  Moreover, there are multiple allelic variants of the 5-HT2C receptor and the receptor is subject to RNA editing in the coding regions.  The complexity of this receptor is further emphasized by the studies suggesting the utility of either agonists or antagonists in the treatment of schizophrenia.  While several 5-HT2C agonists have demonstrated clin. efficacy in obesity (lorcaserin, PRX-000933), the focus of this review is on the therapeutic potential of 5-HT2C agonists in schizophrenia.  To this end, the preclin. profile of 5-HT2C agonists from a neurochem., electrophysiol., and a behavioral perspective is indicative of antipsychotic-like efficacy without extrapyramidal symptoms or wt. gain.  Recently, the selective 5-HT2C agonist vabicaserin demonstrated clin. efficacy in a Phase II trial in schizophrenia patients without wt. gain and with low EPS liability.  These data are highly encouraging and suggest that 5-HT2C agonists are potential therapeutics for the treatment of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuqzYsH56GbVg90H21EOLACvtfcHk0lju-552FMZ3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1GiurY%253D&md5=17bdc34317a7d966bc6038bca83ec5b3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26atitle%3D5-HT%25282C%2529%2520agonists%2520as%2520therapeutics%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26spage%3D147%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mombereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundersen, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span> </span><span class="NLM_article-title">Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=468-473&author=C.+Mombereauauthor=Y.+Kawaharaauthor=B.+B.+Gundersenauthor=K.+Nishikuraauthor=J.+A.+Blendy&title=Functional+relevance+of+serotonin+2C+receptor+mRNA+editing+in+antidepressant-+and+anxiety-like+behaviors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMombereau%26aufirst%3DC.%26aulast%3DKawahara%26aufirst%3DY.%26aulast%3DGundersen%26aufirst%3DB.%2BB.%26aulast%3DNishikura%26aufirst%3DK.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26atitle%3DFunctional%2520relevance%2520of%2520serotonin%25202C%2520receptor%2520mRNA%2520editing%2520in%2520antidepressant-%2520and%2520anxiety-like%2520behaviors%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D59%26spage%3D468%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pazos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J. M.</span><span> </span><span class="NLM_article-title">The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2F0014-2999%2884%2990057-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=6519175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADyaL2MXptVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1984&pages=539-546&author=A.+Pazosauthor=D.+Hoyerauthor=J.+M.+Palacios&title=The+binding+of+serotonergic+ligands+to+the+porcine+choroid+plexus%3A+characterization+of+a+new+type+of+serotonin+recognition+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The binding of serotonergic ligands to the porcine choroid plexus:  characterization of a new type of serotonin recognition site</span></div><div class="casAuthors">Pazos, Angel; Hoyer, Daniel; Palacios, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">539-46</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The kinetic and pharmacol. characteristics of the binding of 3H-labeled 5-HT  [50-67-9], [3H]8-hydroxy-2-di-n-propylaminotetraline, [3H]LSD, [3H]ketanserin, and 3H-labeled mesulergine  [64795-35-3] to membranes from frontal cortex, hippocampus, and choroid plexus of pig brain were studied.  The binding of these ligands to frontal cortex and hippocampus demonstrated the presence of 5-HT1 and 5-HT2 sites in both tissues, although hippocampus was richer in 5-HT1 (subtype 5-HT1A) sites.  [3H]5-HT, [3H]mesulergine, and [3H]LSD labeled the pig choroid plexus with high affinity.  The pharmacol. profiles of [3H]5-HT and [3H]mesulergine binding to this tissue were closely comparable.  Ligands reported as selective for 5-HT1A, 5-HT1B, or 5-HT2 subtypes did not show high affinity for these binding sites.  Therefore, these 5-HT binding sites in pig choroid plexus could be named 5-HT1c.  Other drugs with a high affinity for these sites were methysergide and mianserine.  In pig frontal cortex, [3H]5-HT labeled the different subtypes of 5-HT1 sites.  In contrast, [3H]mesulergine bound in pig frontal cortex to a small population of sites with pharmacol. properties similar to those of the choroid plexus 5-HT1c sites.  Possible physiol. functions in which these sites might be involved are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0l961cuMHyLVg90H21EOLACvtfcHk0lguNPf9ZS8uGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXptVGjuw%253D%253D&md5=bdbf81bd51d54e7238632a6c506dafab</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2884%2990057-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252884%252990057-8%26sid%3Dliteratum%253Aachs%26aulast%3DPazos%26aufirst%3DA.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520binding%2520of%2520serotonergic%2520ligands%2520to%2520the%2520porcine%2520choroid%2520plexus%253A%2520characterization%2520of%2520a%2520new%2520type%2520of%2520serotonin%2520recognition%2520site%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1984%26volume%3D106%26spage%3D539%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Berg, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, U.</span><span> </span><span class="NLM_article-title">Fine-tuning serotonin 2c receptor function in the brain: molecular and functional implications</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=969-976&author=K.+A.+Bergauthor=W.+P.+Clarkeauthor=K.+A.+Cunninghamauthor=U.+Spampinato&title=Fine-tuning+serotonin+2c+receptor+function+in+the+brain%3A+molecular+and+functional+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DSpampinato%26aufirst%3DU.%26atitle%3DFine-tuning%2520serotonin%25202c%2520receptor%2520function%2520in%2520the%2520brain%253A%2520molecular%2520and%2520functional%2520implications%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D969%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">Hallucinogens</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2Fj.pharmthera.2003.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=14761703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=131-181&author=D.+E.+Nichols&title=Hallucinogens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hallucinogens</span></div><div class="casAuthors">Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-181</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Hallucinogens (psychedelics) are psychoactive substances that powerfully alter perception, mood, and a host of cognitive processes.  They are considered physiol. safe and do not produce dependence or addiction.  Their origin predates written history, and they were employed by early cultures in a variety of sociocultural and ritual contexts.  In the 1950s, after the virtually contemporaneous discovery of both serotonin (5-HT) and lysergic acid diethylamide (LSD-25), early brain research focused intensely on the possibility that LSD or other hallucinogens had a serotonergic basis of action and reinforced the idea that 5-HT was an important neurotransmitter in brain.  These ideas were eventually proven, and today it is believed that hallucinogens stimulate 5-HT2A receptors, esp. those expressed on neocortical pyramidal cells.  Activation of 5-HT2A receptors also leads to increased cortical glutamate levels presumably by a presynaptic receptor-mediated release from thalamic afferents.  These findings have led to comparisons of the effects of classical hallucinogens with certain aspects of acute psychosis and to a focus on thalamocortical interactions as key to understanding both the action of these substances and the neuroanatomical sites involved in altered states of consciousness (ASC).  In vivo brain imaging in humans using [18F]fluorodeoxyglucose has shown that hallucinogens increase prefrontal cortical metab., and correlations have been developed between activity in specific brain areas and psychol. elements of the ASC produced by hallucinogens.  The 5-HT2A receptor clearly plays an essential role in cognitive processing, including working memory, and ligands for this receptor may be extremely useful tools for future cognitive neuroscience research.  In addn., it appears entirely possible that utility may still emerge for the use of hallucinogens in treating alcoholism, substance abuse, and certain psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRl6lKmZ_4Y7Vg90H21EOLACvtfcHk0lguNPf9ZS8uGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D&md5=7b5246f6479d76736c5a7223c60a9e99</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2003.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2003.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DHallucinogens%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D101%26spage%3D131%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span> </span><span class="NLM_article-title">5-HT2C receptor modulators: a patent survey</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1517%2F13543776.2010.518956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=20849206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1429-1455&author=J.+Leeauthor=M.+E.+Jungauthor=J.+Lee&title=5-HT2C+receptor+modulators%3A+a+patent+survey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor modulators: a patent survey</span></div><div class="casAuthors">Lee, Junwon; Jung, Myung Eun; Lee, Jinhwa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1455</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT2C receptor is a GPCR and is one of the 14 subtypes that constitute the serotonin receptor family.  The 5-HT2C receptor is exclusively expressed in the CNS where it demonstrates a wide distribution and displays high-affinity interactions with a wide variety of psychiatric medications.  Modulators of 5-HT2C have been implicated as a potential treatment for diseases of significant unmet medical need, including obesity, schizophrenia, depression, anxiety, Parkinson's disease, drug addiction, erectile dysfunction and urinary incontinence.  Thus, there is a great interest in developing potent and selective 5-HT2C receptor modulators.  Areas covered in this review: This review article highlights the research progress in 5-HT2C receptor modulators published in the patent literature between Jan. 2003 and June 2010, giving emphasis to the medicinal chemist's standpoint.  What the reader will gain: Readers will rapidly gain an overview of the various 5-HT2C receptor modulators reported in the patent literature in the past 8 years.  Furthermore, the readers will learn which structure type can interact with the 5-HT2C receptor.  In addn., the readers will be aware of the pharmaceutical companies that have been the main players in the field.  Take home message: There is substantial evidence supporting the concept that a selective 5-HT2C receptor modulator should provide benefit in the treatment of a variety of CNS disorders.  Although research efforts have identified several promising 5-HT2C receptor modulators that display high functional selectivity, further clin. efficacy and safety data are needed to prove their actual clin. utility.  Therefore, the query for selectively acting 5-HT2C receptor modulators is still ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsaQEKrg_R7Vg90H21EOLACvtfcHk0lguNPf9ZS8uGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF&md5=43397f74d27751efdc505165ba96172c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3D5-HT2C%2520receptor%2520modulators%253A%2520a%2520patent%2520survey%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1429%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Thomsen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzaghi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes-Saldana, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espitia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuskin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D.</span><span> </span><span class="NLM_article-title">Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1124%2Fjpet.107.133348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=18252809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=577-587&author=W.+J.+Thomsenauthor=A.+J.+Grottickauthor=F.+Menzaghiauthor=H.+Reyes-Saldanaauthor=S.+Espitiaauthor=D.+Yuskinauthor=K.+Whelanauthor=M.+Martinauthor=M.+Morganauthor=W.+Chenauthor=H.+Al-Shammaauthor=B.+Smithauthor=D.+Chalmersauthor=D.+Behan&title=Lorcaserin%2C+a+novel+selective+human+5-hydroxytryptamine2C+agonist%3A+in+vitro+and+in+vivo+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization</span></div><div class="casAuthors">Thomsen, William J.; Grottick, Andrew J.; Menzaghi, Frederique; Reyes-Saldana, Hazel; Espitia, Stephen; Yuskin, Diane; Whelan, Kevin; Martin, Michael; Morgan, Michael; Chen, Weichao; Al-Shamma, Hussein; Smith, Brian; Chalmers, Derek; Behan, Dominic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">577-587</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)2C receptor agonists hold promise for the treatment of obesity.  In this study, we describe the in vitro and in vivo characteristics of lorcaserin [(1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3 benzazepine], a selective, high affinity 5-HT2C full agonist.  Lorcaserin bound to human and rat 5-HT2C receptors with high affinity (Ki = 15±1 nM, 29±7 nM, resp.), and it was a full agonist for the human 5-HT2C receptor in a functional inositol phosphate accumulation assay, with 18- and 104-fold selectivity over 5-HT2A and 5-HT2B receptors, resp.  Lorcaserin was also highly selective for human 5-HT2C over other human 5-HT receptors (5-HT1A, 5-HT3, 5-HT4C, 5-HT55A, 5-HT6, and 5-HT7), in addn. to a panel of 67 other G protein-coupled receptors and ion channels.  Lorcaserin did not compete for binding of ligands to serotonin, dopamine, and norepinephrine transporters, and it did not alter their function in vitro.  Behavioral observations indicated that unlike the 5-HT2A agonist (±)-1-(2,5-dimethoxy-4-phenyl)-2-aminopropane, lorcaserin did not induce behavioral changes indicative of functional 5-HT2A agonist activity.  Acutely, lorcaserin reduced food intake in rats, an effect that was reversed by pretreatment with the 5-HT2C-selective antagonist 6-chloro-5-methyl-1-[6-(2-methylpyridin-3-yloxy)pyridin-3-yl-carbamoyl]indoline (SB242,084) but not the 5-HT2A antagonist (R)-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol (MDL 100,907), demonstrating mediation by the 5-HT2C receptor.  Chronic daily treatment with lorcaserin to rats maintained on a high fat diet produced dose-dependent redns. in food intake and body wt. gain that were maintained during the 4-wk study.  Upon discontinuation, body wt. returned to control levels.  These data demonstrate lorcaserin to be a potent, selective, and efficacious agonist of the 5-HT2C receptor, with potential for the treatment of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqDHE28aF3k7Vg90H21EOLACvtfcHk0ljWUm2AU32L8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D&md5=0626c3dabb7e89066e45ecd12cbc81f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133348%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DMenzaghi%26aufirst%3DF.%26aulast%3DReyes-Saldana%26aufirst%3DH.%26aulast%3DEspitia%26aufirst%3DS.%26aulast%3DYuskin%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DChalmers%26aufirst%3DD.%26aulast%3DBehan%26aufirst%3DD.%26atitle%3DLorcaserin%252C%2520a%2520novel%2520selective%2520human%25205-hydroxytryptamine2C%2520agonist%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D577%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span> </span><span class="NLM_article-title">Lorcaserin. In obesity: unacceptable risks</span>.  <span class="citation_source-journal">Prescrire Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=24926508" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Lorcaserin.+In+obesity%3A+unacceptable+risks.+Prescrire+Int.+2014%2C+23%2C+117%E2%80%93120."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DLorcaserin.%2520In%2520obesity%253A%2520unacceptable%2520risks%26jtitle%3DPrescrire%2520Int.%26date%3D2014%26volume%3D23%26spage%3D117%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiros, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, H.</span><span> </span><span class="NLM_article-title">Prediction of Efficacy of Vabicaserin, a 5-HT2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model</span> <span class="citation_source-journal">CPT Pharmacometrics Syst. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=e111&author=J.+Liuauthor=A.+Ogdenauthor=T.+A.+Comeryauthor=A.+Spirosauthor=P.+Robertsauthor=H.+Geerts&title=Prediction+of+Efficacy+of+Vabicaserin%2C+a+5-HT2C+Agonist%2C+for+the+Treatment+of+Schizophrenia+Using+a+Quantitative+Systems+Pharmacology+Model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DOgden%26aufirst%3DA.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DSpiros%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DP.%26aulast%3DGeerts%26aufirst%3DH.%26atitle%3DPrediction%2520of%2520Efficacy%2520of%2520Vabicaserin%252C%2520a%25205-HT2C%2520Agonist%252C%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%2520Using%2520a%2520Quantitative%2520Systems%2520Pharmacology%2520Model%26jtitle%3DCPT%2520Pharmacometrics%2520Syst.%2520Pharmacol.%26date%3D2014%26volume%3D3%26spage%3De111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawoschik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1124%2Fjpet.111.179572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=21402690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFeiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=2011&pages=673-680&author=J.+Dunlopauthor=S.+W.+Wattsauthor=J.+E.+Barrettauthor=J.+Coupetauthor=B.+Harrisonauthor=H.+Mazandaraniauthor=S.+Nawoschikauthor=M.+N.+Pangalosauthor=S.+Ramamoorthyauthor=L.+Schechterauthor=D.+Smithauthor=G.+Stackauthor=J.+Zhangauthor=G.+Zhangauthor=S.+Rosenzweig-Lipson&title=Characterization+of+vabicaserin+%28SCA-136%29%2C+a+selective+5-hydroxytryptamine+2C+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist</span></div><div class="casAuthors">Dunlop, John; Watts, Stephanie W.; Barrett, James E.; Coupet, Joseph; Harrison, Boyd; Mazandarani, Hossein; Nawoschik, Stanley; Pangalos, Menelas N.; Ramamoorthy, Siva; Schechter, Lee; Smith, Deborah; Stack, Gary; Zhang, Jean; Zhang, Guoming; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-680</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The 5-hydroxytryptamine 2C (5-HT2C) receptor subtype has received considerable attention as a target for drug discovery, having been implicated in a wide variety of disorders.  Here, we describe the in vitro pharmacol. profile of the novel 5-HT2C receptor-selective agonist vabicaserin [(-)-4,5,6,7,9,9a,10,11,12,12a-decahydrocyclopenta[c] [1,4]diazepino[6,7,1-ij]quinoline hydrochloride] (SCA-136), including a comprehensive strategy to assess 5-HT2B receptor selectivity using diverse prepns. and assays of receptor activation.  Vabicaserin displaced 125I-(2,5-dimethoxy)phenylisopropylamine binding from human 5-HT2C receptor sites in Chinese hamster ovary cell membranes with a Ki value of 3 nM and was > 50-fold selective over a no. of serotonergic, noradrenergic, and dopaminergic receptors.  Binding affinity detd. for the human 5-HT2B receptor subtype using [3H]5HT was 14 nM.  Vabicaserin was a potent and full agonist (EC50, 8 nM; Emax, 100%) in stimulating 5-HT2C receptor-coupled calcium mobilization and exhibited 5-HT2A receptor antagonism and 5-HT2B antagonist or partial agonist activity in transfected cells, depending on the level of receptor expression.  In rat stomach fundus and human colonic longitudinal muscle endogenously expressing 5-HT2B receptors, vabicaserin failed to induce a 5-HT2B receptor-dependent contraction and produced a rightward shift of the 5-HT and α-methyl-5-HT concn.-response curves in these prepns., resp., consistent with 5-HT2B competitive antagonism.  Likewise, vabicaserin failed to induce a 5-HT2B receptor-mediated contraction in arteries from deoxycorticosterone acetate-salt-treated rats, a model of hypersensitized 5-HT2B receptor function, and produced a rightward shift in the 5-HT-induced response that was consistent with 5-HT2B receptor antagonism.  In summary, vabicaserin is a novel, potent, and selective 5-HT2C receptor agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCYu5_bxpVxbVg90H21EOLACvtfcHk0ljWUm2AU32L8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFeiur8%253D&md5=0426498cda326da150beedcebcb56aa5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.179572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.179572%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DWatts%26aufirst%3DS.%2BW.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DNawoschik%26aufirst%3DS.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DSchechter%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520vabicaserin%2520%2528SCA-136%2529%252C%2520a%2520selective%25205-hydroxytryptamine%25202C%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D337%26spage%3D673%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">WAY-163909 [(7b<i>R</i>,10a<i>R</i>)-1,2,3,4,8,9,10,10a-octahydro-7b<i>H</i>-cyclopenta-[<i>b</i>][1,4]diazepino[6,7,1-<i>hi</i> ]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1124%2Fjpet.106.106989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=17038512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=486-496&author=K.+L.+Marquisauthor=A.+L.+Sabbauthor=S.+F.+Logueauthor=J.+A.+Brennanauthor=M.+J.+Pieslaauthor=T.+A.+Comeryauthor=S.+M.+Grauerauthor=C.+R.+Ashbyauthor=H.+Q.+Nguyenauthor=L.+A.+Dawsonauthor=J.+E.+Barrettauthor=G.+Stackauthor=H.+Y.+Meltzerauthor=B.+L.+Harrisonauthor=S.+Rosenzweig-Lipson&title=WAY-163909+%5B%287bR%2C10aR%29-1%2C2%2C3%2C4%2C8%2C9%2C10%2C10a-octahydro-7bH-cyclopenta-%5Bb%5D%5B1%2C4%5Ddiazepino%5B6%2C7%2C1-hi+%5Dindole%5D%3A+A+novel+5-hydroxytryptamine+2C+receptor-selective+agonist+with+preclinical+antipsychotic-like+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span></div><div class="casAuthors">Marquis, Karen L.; Sabb, Annmarie L.; Logue, Sheree F.; Brennan, Julie A.; Piesla, Michael J.; Comery, Tom A.; Grauer, Steven M.; Ashby, Charles R., Jr.; Nguyen, Huy Q.; Dawson, Lee A.; Barrett, James E.; Stack, Gary; Meltzer, Herbert Y.; Harrison, Boyd L.; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Serotonin-2C (5-HT2C) receptor antagonists and agonists have been shown to affect dopamine (DA) neurotransmission, with agonists selectively decreasing mesolimbic DA.  As antipsychotic efficacy is proposed to be assocd. with decreased mesolimbic DA neurotransmission by virtue of DA D2 receptor antagonism, the 5-HT2C-selective receptor agonist, WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], was evaluated in animal models of schizophrenia and in vivo microdialysis and electrophysiol. to det. the effects on mesolimbic and nigrostriatal DA neurotransmission.  Similar to clozapine, WAY-163909 (1.7-30 mg/kg i.p.) decreased apomorphine-induced climbing with little effect on stereotypy and no significant induction of catalepsy.  WAY-163909 (0.3-3 mg/kg s.c.) more potently reduced phencyclidine-induced locomotor activity compared with d-amphetamine with no effect on spontaneous activity.  WAY-163909 (1.7-17 mg/kg i.p.) reversed MK-801 (5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate)- and DOI [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane]-disrupted prepulse inhibition of startle (PPI) and improved PPI in DBA/2N mice.  In conditioned avoidance responding, WAY-163909 (0.3-3 mg/kg i.p.; 1-17 mg/kg p.o.) reduced avoidance responding, an effect blocked by the 5-HT2B/2C receptor antagonist SB 206553 [5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole].  WAY-163909 (10 mg/kg s.c.) selectively decreased extracellular levels of DA in the nucleus accumbens without affecting the striatum.  Likewise, in vivo electrophysiol. recordings showed a decrease in the no. of spontaneously firing DA neurons in the ventral tegmental area but not in the substantia nigra with both acute and chronic (21-day) administration of WAY-163909 (1-10 mg/kg i.p.).  Thus, the profile of the 5-HT2C selective receptor agonist WAY-163909 is similar to that of an atypical antipsychotic and addnl. may have rapid onset properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemOaXlISXJrVg90H21EOLACvtfcHk0lj5AmoYFhEDgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D&md5=f70bb5a91c306aa208b5a19cd2e21937</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106989%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DWAY-163909%2520%255B%25287bR%252C10aR%2529-1%252C2%252C3%252C4%252C8%252C9%252C10%252C10a-octahydro-7bH-cyclopenta-%255Bb%255D%255B1%252C4%255Ddiazepino%255B6%252C7%252C1-hi%2520%255Dindole%255D%253A%2520A%2520novel%25205-hydroxytryptamine%25202C%2520receptor-selective%2520agonist%2520with%2520preclinical%2520antipsychotic-like%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D486%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, P. A.</span><span> </span><span class="NLM_article-title">CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2Fj.neuropharm.2006.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=16949622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=279-290&author=J.+A.+Siuciakauthor=D.+S.+Chapinauthor=S.+A.+McCarthyauthor=V.+Guanowskyauthor=J.+Brownauthor=P.+Chiangauthor=R.+Maralaauthor=T.+Pattersonauthor=P.+A.+Seymourauthor=A.+Swickauthor=P.+A.+Iredale&title=CP-809%2C101%2C+a+selective+5-HT2C+agonist%2C+shows+activity+in+animal+models+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity</span></div><div class="casAuthors">Siuciak, Judith A.; Chapin, Douglas S.; McCarthy, Sheryl A.; Guanowsky, Victor; Brown, Janice; Chiang, Phoebe; Marala, Ravi; Patterson, Terrell; Seymour, Patricia A.; Swick, Andrew; Iredale, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-290</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CP-809,101 is a potent, functionally selective 5-HT2C agonist that displays approx. 100% efficacy in vitro.  The aim of the present studies was to assess the efficacy of a selective 5-HT2C agonist in animal models predictive of antipsychotic-like efficacy and side-effect liability.  Similar to currently available antipsychotic drugs, CP-809,101 dose-dependently inhibited conditioned avoidance responding (CAR, ED50 = 4.8 mg/kg, s.c.).  The efficacy of CP-809,101 in CAR was completely antagonized by the concurrent administration of the 5-HT2C receptor antagonist, SB-224,282.  CP-809,101 antagonized both PCP- and d-amphetamine-induced hyperactivity with ED50 values of 2.4 and 2.9 mg/kg (s.c.), resp. and also reversed an apomorphine induced-deficit in prepulse inhibition.  At doses up to 56 mg/kg, CP-809,101 did not produce catalepsy.  Thus, the present results demonstrate that the 5-HT2C agonist, CP-809,101, has a pharmacol. profile similar to that of the atypical antipsychotics with low extrapyramidal symptom liability.  CP-809,101 was inactive in two animal models of antidepressant-like activity, the forced swim test and learned helplessness.  However, CP-809,101 was active in novel object recognition, an animal model of cognitive function.  These data suggest that 5-HT2C agonists may be a novel approach in the treatment of psychosis as well as for the improvement of cognitive dysfunction assocd. with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHuHmkKSf1jrVg90H21EOLACvtfcHk0lj5AmoYFhEDgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D&md5=5b422611bae3df8a9bcf71f84f1bbc37</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DMarala%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSwick%26aufirst%3DA.%26aulast%3DIredale%26aufirst%3DP.%2BA.%26atitle%3DCP-809%252C101%252C%2520a%2520selective%25205-HT2C%2520agonist%252C%2520shows%2520activity%2520in%2520animal%2520models%2520of%2520antipsychotic%2520activity%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D279%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffing, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lame, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coelho, R. V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliman, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schildknegt, K.</span><span> </span><span class="NLM_article-title">Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">848</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=848-858&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvieauthor=J.+Aubrechtauthor=E.+B.+Smithauthor=S.+L.+Coffingauthor=J.+R.+Cheungauthor=C.+Vageauthor=M.+E.+Lameauthor=P.+Chiangauthor=K.+F.+McClureauthor=T.+S.+Maurerauthor=R.+V.+Coelhoauthor=V.+F.+Solimanauthor=K.+Schildknegt&title=Genotoxicity+of+2-%283-chlorobenzyloxy%29-6-%28piperazinyl%29pyrazine%2C+a+novel+5-hydroxytryptamine2c+receptor+agonist+for+the+treatment+of+obesity%3A+role+of+metabolic+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26aulast%3DCoffing%26aufirst%3DS.%2BL.%26aulast%3DCheung%26aufirst%3DJ.%2BR.%26aulast%3DVage%26aufirst%3DC.%26aulast%3DLame%26aufirst%3DM.%2BE.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DSoliman%26aufirst%3DV.%2BF.%26aulast%3DSchildknegt%26aufirst%3DK.%26atitle%3DGenotoxicity%2520of%25202-%25283-chlorobenzyloxy%2529-6-%2528piperazinyl%2529pyrazine%252C%2520a%2520novel%25205-hydroxytryptamine2c%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520obesity%253A%2520role%2520of%2520metabolic%2520activation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D848%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Callahan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, K. A.</span><span> </span><span class="NLM_article-title">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of <i>m</i>-chlorophenylpiperazine (mCPP)</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2F0014-2999%2894%2990690-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=8082704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1994&pages=27-38&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Involvement+of+5-HT2C+receptors+in+mediating+the+discriminative+stimulus+properties+of+m-chlorophenylpiperazine+%28mCPP%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)</span></div><div class="casAuthors">Callahan, Patrick M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-38</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats were trained to discriminate the 5-HT receptor agonist m-chlorophenylpiperazine (mCPP; 1 mg/kg) from saline using a two-lever, water-reinforced drug discrimination task.  The antidepressant trazodone (1-8 mg/kg), the 5-HT1B/2C receptor agonists 1-(m-trifluoromethylphenyl)piperazine (TFMPP; 0.25-1 mg/kg) and MK 212 (0.125-1 mg/kg), and the mixed 5-HT1A/B receptor agonist RU 24969 (0.25-2 mg/kg) substituted fully for mCPP.  The 5-HT2A/2C receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI; 0.25-1 mg/kg) and d-lysergic acid diethylamide (LSD; 0.02-0.08 mg/kg) and the 5-HT releaser fenfluramine (0.5-2 mg/kg) also mimicked mCPP.  Agonists selective for the 5-HT1A or 5-HT3 receptor or the 5-HT reuptake site produced saline-lever responding.  The ergoline deriv. mesulergine (0.5-4 mg/kg) produced a partial agonist/antagonist profile.  The 5-HT1/2 receptor antagonist metergoline (0.125-1 mg/kg) completely blocked the mCPP cue whereas the 5-HT2A/2C receptor antagonists ketanserin and LY 53857 as well as all other 5-HT receptor antagonists failed to block the mCPP cue.  The dopamine receptor antagonists SCH 23390 and haloperidol were also ineffective mCPP antagonists.  Following pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (pCPA; 100 mg/kg/day) for 3 consecutive days, the discriminability of low doses of mCPP increased, whereas the effects of fenfluramine decreased.  The present results suggest that the discriminative stimulus effects of mCPP in rats are mediated primarily by postsynaptic 5-HT2C receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebmnBj2zsK7Vg90H21EOLACvtfcHk0lj5AmoYFhEDgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D&md5=98623ad672842986facfc5cf3fa0a345</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990690-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990690-4%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DInvolvement%2520of%25205-HT2C%2520receptors%2520in%2520mediating%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520m-chlorophenylpiperazine%2520%2528mCPP%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D257%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fiorella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. C.</span><span> </span><span class="NLM_article-title">5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of <i>m</i>-chlorophenylpiperazine</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1007%2FBF02246545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=8748393" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1995&pages=237-243&author=D.+Fiorellaauthor=S.+Helsleyauthor=R.+A.+Rabinauthor=J.+C.+Winter&title=5-HT2C+receptor-mediated+phosphoinositide+turnover+and+the+stimulus+effects+of+m-chlorophenylpiperazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2FBF02246545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02246545%26sid%3Dliteratum%253Aachs%26aulast%3DFiorella%26aufirst%3DD.%26aulast%3DHelsley%26aufirst%3DS.%26aulast%3DRabin%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DJ.%2BC.%26atitle%3D5-HT2C%2520receptor-mediated%2520phosphoinositide%2520turnover%2520and%2520the%2520stimulus%2520effects%2520of%2520m-chlorophenylpiperazine%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D1995%26volume%3D122%26spage%3D237%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cho, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurome, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1902</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801354e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1885-1902&author=S.+J.+Choauthor=N.+H.+Jensenauthor=T.+Kuromeauthor=S.+Kadariauthor=M.+L.+Manzanoauthor=J.+E.+Malbergauthor=B.+Caldaroneauthor=B.+L.+Rothauthor=A.+P.+Kozikowski&title=Selective+5-hydroxytryptamine+2C+receptor+agonists+derived+from+the+lead+compound+tranylcypromine%3A+identification+of+drugs+with+antidepressant-like+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm801354e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801354e%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DKurome%26aufirst%3DT.%26aulast%3DKadari%26aufirst%3DS.%26aulast%3DManzano%26aufirst%3DM.%2BL.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%25205-hydroxytryptamine%25202C%2520receptor%2520agonists%2520derived%2520from%2520the%2520lead%2520compound%2520tranylcypromine%253A%2520identification%2520of%2520drugs%2520with%2520antidepressant-like%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1885%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svennebring, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1221-1225&author=A.+P.+Kozikowskiauthor=S.+J.+Choauthor=N.+H.+Jensenauthor=J.+A.+Allenauthor=A.+M.+Svennebringauthor=B.+L.+Roth&title=HTS+and+rational+drug+design+to+generate+a+class+of+5-HT%282C%29-selective+ligands+for+possible+use+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DSvennebring%26aufirst%3DA.%2BM.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DHTS%2520and%2520rational%2520drug%2520design%2520to%2520generate%2520a%2520class%2520of%25205-HT%25282C%2529-selective%2520ligands%2520for%2520possible%2520use%2520in%2520schizophrenia%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1221%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svennebring, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200206z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=929-932&author=G.+Chenauthor=S.+J.+Choauthor=X.+P.+Huangauthor=N.+H.+Jensenauthor=A.+Svennebringauthor=M.+F.+Sassanoauthor=B.+L.+Rothauthor=A.+P.+Kozikowski&title=Rational+Drug+Design+Leading+to+the+Identification+of+a+Potent+5-HT%282C%29+Agonist+Lacking+5-HT%282B%29+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fml200206z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200206z%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DSvennebring%26aufirst%3DA.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520Drug%2520Design%2520Leading%2520to%2520the%2520Identification%2520of%2520a%2520Potent%25205-HT%25282C%2529%2520Agonist%2520Lacking%25205-HT%25282B%2529%2520Activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D929%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanaoka, M.</span><span> </span><span class="NLM_article-title">Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=1480-1494&author=K.+Yamazakiauthor=M.+Kanaoka&title=Computational+prediction+of+the+plasma+protein-binding+percent+of+diverse+pharmaceutical+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKanaoka%26aufirst%3DM.%26atitle%3DComputational%2520prediction%2520of%2520the%2520plasma%2520protein-binding%2520percent%2520of%2520diverse%2520pharmaceutical%2520compounds%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26spage%3D1480%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span> </span><span class="NLM_article-title">Predictive in silico modeling for hERG channel blockers</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1016%2FS1359-6446%2804%2903278-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=15718164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=149-155&author=A.+M.+Aronov&title=Predictive+in+silico+modeling+for+hERG+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive in silico modeling for hERG channel blockers</span></div><div class="casAuthors">Aronov, Alex M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-155</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  HERG-mediated sudden death as a side effect of non-antiarrhythmic drugs has been receiving increased regulatory attention.  Perhaps owing to the unique shape of the ligand-binding site and its hydrophobic character, the hERG channel has been shown to interact with pharmaceuticals of widely varying structure.  Several in silico approaches have attempted to predict hERG channel blockade.  Some of these approaches are aimed primarily at filtering out potential hERG blockers in the context of virtual libraries, others involve understanding structure-activity relationships governing hERG-drug interactions.  This review summarizes the most recent efforts in this emerging field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDgIcgWdJQJrVg90H21EOLACvtfcHk0ljQnNN8wODo2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFarsbY%253D&md5=112b79a48e3d6f5ab3e313f00cf2a4fa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903278-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903278-7%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DPredictive%2520in%2520silico%2520modeling%2520for%2520hERG%2520channel%2520blockers%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D149%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Turpeinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanger, U. M.</span><span> </span><span class="NLM_article-title">Cytochrome P450 2B6: function, genetics, and clinical relevance</span> <span class="citation_source-journal">Drug Metab. Drug Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1515%2Fdmdi-2012-0027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=23152403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFWrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=185-197&author=M.+Turpeinenauthor=U.+M.+Zanger&title=Cytochrome+P450+2B6%3A+function%2C+genetics%2C+and+clinical+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 2B6: function, genetics, and clinical relevance</span></div><div class="casAuthors">Turpeinen, Miia; Zanger, Ulrich M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Drug Interactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">185-197</span>CODEN:
                <span class="NLM_cas:coden">DMDIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0792-5077</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Cytochrome P 450 (CYP) 2B6 belongs to the set of important hepatic drug-metabolizing CYPs.  It makes up roughly 3%-6% of total hepatic CYP content and metabolizes several pharmaceuticals including bupropion, efavirenz, cyclophosphamide, pethidine, ketamine and propofol.  The enzyme is susceptible to drug-drug interactions by enzyme induction and inhibition.  In addn. to drugs, CYP2B6 is able to both detoxify and bioactivate a no. of procarcinogens and environmental agents including pesticides and herbicides.  There is an extensive interindividual variability in the expression of CYP2B6, which is in part explained by extensive genetic polymorphism.  CYP2B6 is one of the most polymorphic CYP genes in humans with over 100 described SNPs, numerous complex haplotypes and distinct ethnic and racial frequencies.  This review summarizes the basic properties of CYP2B6 and the main characteristics of clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjYWI7Tpi-erVg90H21EOLACvtfcHk0ljmbKg706TbOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFWrsbg%253D&md5=924b1c1ce4ad42a6e7f3c10255803cf7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1515%2Fdmdi-2012-0027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fdmdi-2012-0027%26sid%3Dliteratum%253Aachs%26aulast%3DTurpeinen%26aufirst%3DM.%26aulast%3DZanger%26aufirst%3DU.%2BM.%26atitle%3DCytochrome%2520P450%25202B6%253A%2520function%252C%2520genetics%252C%2520and%2520clinical%2520relevance%26jtitle%3DDrug%2520Metab.%2520Drug%2520Interact.%26date%3D2012%26volume%3D27%26spage%3D185%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span> </span><span class="NLM_article-title">Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=953-955&author=M.+J.+Millanauthor=A.+Dekeyneauthor=A.+Gobert&title=Serotonin+%285-HT%292C+receptors+tonically+inhibit+dopamine+%28DA%29+and+noradrenaline+%28NA%29%2C+but+not+5-HT%2C+release+in+the+frontal+cortex+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DSerotonin%2520%25285-HT%25292C%2520receptors%2520tonically%2520inhibit%2520dopamine%2520%2528DA%2529%2520and%2520noradrenaline%2520%2528NA%2529%252C%2520but%2520not%25205-HT%252C%2520release%2520in%2520the%2520frontal%2520cortex%2520in%2520vivo%26jtitle%3DNeuropharmacology%26date%3D1998%26volume%3D37%26spage%3D953%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Di Giovanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Matteo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Mascio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span> </span><span class="NLM_article-title">Preferential modulation of mesolimbic vs nigrostriatal dopaminergic function by serotonin (2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=53-61&author=G.+Di+Giovanniauthor=V.+Di+Matteoauthor=M.+Di+Mascioauthor=E.+Esposito&title=Preferential+modulation+of+mesolimbic+vs+nigrostriatal+dopaminergic+function+by+serotonin+%282C%2F2B%29+receptor+agonists%3A+a+combined+in+vivo+electrophysiological+and+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiovanni%26aufirst%3DG.%26aulast%3DDi%2BMatteo%26aufirst%3DV.%26aulast%3DDi%2BMascio%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DE.%26atitle%3DPreferential%2520modulation%2520of%2520mesolimbic%2520vs%2520nigrostriatal%2520dopaminergic%2520function%2520by%2520serotonin%2520%25282C%252F2B%2529%2520receptor%2520agonists%253A%2520a%2520combined%2520in%2520vivo%2520electrophysiological%2520and%2520microdialysis%2520study%26jtitle%3DSynapse%26date%3D2000%26volume%3D35%26spage%3D53%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">5-HT2 receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.2174%2F1568007043482598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=14965241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=11-26&author=J.+E.+Leysen&title=5-HT2+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2 receptors</span></div><div class="casAuthors">Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT2 receptors are G-protein coupled receptors that currently comprise 3 subtypes: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  The subtypes are related in their mol. structure, amino acid sequence, and signaling properties.  5-HT2A and 5-HT2C receptors have a widespread distribution and function in the central nervous system.  5-HT2A and 5-HT2C receptor antagonism is a property of certain antipsychotic and antidepressant drugs.  5-HT2B receptors have a restricted expression in the central nervous system.  They have an important role in embryogenesis and in the periphery.  In this article, selected aspects of 5-HT2 receptor research are reviewed for each subtype under 3 main headings: (1) genes, protein structure, and receptor signaling; (2) receptor localization with emphasis on the CNS, and (3) compds.  The general discussion reflects on the reasons for the limited success in the clinic of 5-HT2 receptor subtype selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGTjJwjn8erVg90H21EOLACvtfcHk0ljmbKg706TbOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D&md5=9f7316c92e674a8c1cf7b13f48d9711a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F1568007043482598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482598%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3D5-HT2%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wacker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorvy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structural features for functional selectivity at serotonin receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1126%2Fscience.1232808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=23519215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=615-619&author=D.+Wackerauthor=C.+Wangauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=E.+Vardyauthor=J.+D.+McCorvyauthor=Y.+Jiangauthor=M.+Chuauthor=F.+Y.+Siuauthor=W.+Liuauthor=H.+E.+Xuauthor=V.+Cherezovauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+features+for+functional+selectivity+at+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features for Functional Selectivity at Serotonin Receptors</span></div><div class="casAuthors">Wacker, Daniel; Wang, Chong; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Jiang, Yi; Chu, Meihua; Siu, Fai Yiu; Liu, Wei; Xu, H. Eric; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">615-619</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Drugs active at G protein-coupled receptors (GPCRs) can differentially modulate either canonical or noncanonical signaling pathways via a phenomenon known as functional selectivity or biased signaling.  The authors report biochem. studies showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ERG), and related ergolines display strong functional selectivity for β-arrestin signaling at the 5-HT2B 5-hydroxytryptamine (5-HT) receptor, whereas they are relatively unbiased at the 5-HT1B receptor.  To investigate the structural basis for biased signaling, the authors detd. the crystal structure of the human 5-HT2B receptor bound to ERG and compared it with the 5-HT1B/ERG structure.  Given the relatively poor understanding of GPCR structure and function to date, insight into different GPCR signaling pathways is important to better understand both adverse and favorable therapeutic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreo_QegM-j7bVg90H21EOLACvtfcHk0ljmbKg706TbOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D&md5=16e96d0255be3ac367aeda7187aa4c15</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232808%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520features%2520for%2520functional%2520selectivity%2520at%2520serotonin%2520receptors%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D615%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Marti-Renom, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sali, A.</span><span> </span><span class="NLM_article-title">Comparative protein structure modeling of genes and genomes</span> <span class="citation_source-journal">Annu. Rev. Biophys. Biomol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5019274&amp;key=10.1146%2Fannurev.biophys.29.1.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5019274&amp;key=10940251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=291-325&author=M.+A.+Marti-Renomauthor=A.+C.+Stuartauthor=A.+Fiserauthor=R.+Sanchezauthor=F.+Meloauthor=A.+Sali&title=Comparative+protein+structure+modeling+of+genes+and+genomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative protein structure modeling of genes and genomes</span></div><div class="casAuthors">Marti-Renom, Marc A.; Stuart, Ashley C.; Fiser, Andras; Sanchez, Roberto; Melo, Francisco; Sali, Andrej</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biophysics and Biomolecular Structure</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-325</span>CODEN:
                <span class="NLM_cas:coden">ABBSE4</span>;
        ISSN:<span class="NLM_cas:issn">1056-8700</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 212 refs.  Comparative modeling predicts the three-dimensional structure of a given protein sequence (target) based primarily on its alignment to one or more proteins of known structure (templates).  The prediction process consists of fold assignment, target-template alignment, model building, and model evaluation.  The no. of protein sequences that can be modeled and the accuracy of the predictions are increasing steadily because of the growth in the no. of known protein structures and because of the improvements in the modeling software.  Further advances are necessary in recognizing weak sequence-structure similarities, aligning sequences with structures, modeling of rigid body shifts, distortions, loops and side chains, as well as detecting errors in a model.  Despite these problems, it is currently possible to model with useful accuracy significant parts of approx. one third of all known protein sequences.  The use of individual comparative models in biol. is already rewarding and increasingly widespread.  A major new challenge for comparative modeling is the integration of it with the torrents of data from genome sequencing projects as well as from functional and structural genomics.  In particular, there is a need to develop an automated, rapid, robust, sensitive, and accurate comparative modeling pipeline applicable to whole genomes.  Such large-scale modeling is likely to encourage new kinds of applications for the many resulting models, based on their large no. and completeness at the level of the family, organism, or functional network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq45B6Amw-zi7Vg90H21EOLACvtfcHk0lhqCtm2reAxjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFOnur0%253D&md5=d97ffe6c47c4a3bae2bbbf14c045afdd</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biophys.29.1.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biophys.29.1.291%26sid%3Dliteratum%253Aachs%26aulast%3DMarti-Renom%26aufirst%3DM.%2BA.%26aulast%3DStuart%26aufirst%3DA.%2BC.%26aulast%3DFiser%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DMelo%26aufirst%3DF.%26aulast%3DSali%26aufirst%3DA.%26atitle%3DComparative%2520protein%2520structure%2520modeling%2520of%2520genes%2520and%2520genomes%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D2000%26volume%3D29%26spage%3D291%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Korb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutzle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span><span> </span><span class="NLM_article-title">Empirical scoring functions for advanced protein-ligand docking with PLANTS</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci800298z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5019274&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=84-96&author=O.+Korbauthor=T.+Stutzleauthor=T.+E.+Exner&title=Empirical+scoring+functions+for+advanced+protein-ligand+docking+with+PLANTS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS</span></div><div class="casAuthors">Korb, Oliver; Stuetzle, Thomas; Exner, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-96</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper we present two empirical scoring functions, PLANTSCHEMPLP and PLANTSPLP, designed for our docking algorithm PLANTS (Protein-Ligand ANT System), which is based on ant colony optimization (ACO).  They are related, regarding their functional form, to parts of already published scoring functions and force fields.  The parametrization procedure described here was able to identify several parameter settings showing an excellent performance for the task of pose prediction on two test sets comprising 298 complexes in total.  Up to 87% of the complexes of the Astex diverse set and 77% of the CCDC/Astex clean listnc (noncovalently bound complexes of the clean list) could be reproduced with root-mean-square deviations of less than 2 Å with respect to the exptl. detd. structures.  A comparison with the state-of-the-art docking tool GOLD clearly shows that this is, esp. for the druglike Astex diverse set, an improvement in pose prediction performance.  Addnl., optimized parameter settings for the search algorithm were identified, which can be used to balance pose prediction reliability and search speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_kyR7CGk9mbVg90H21EOLACvtfcHk0lhqCtm2reAxjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVSquw%253D%253D&md5=fce960b75b9f8906354b7c97ff84c092</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fci800298z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800298z%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DStutzle%26aufirst%3DT.%26aulast%3DExner%26aufirst%3DT.%2BE.%26atitle%3DEmpirical%2520scoring%2520functions%2520for%2520advanced%2520protein-ligand%2520docking%2520with%2520PLANTS%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D84%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RH1','PDB','2RH1'); return false;">PDB: 2RH1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IB4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IB4','PDB','4IB4'); return false;">PDB: 4IB4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SN6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3SN6','PDB','3SN6'); return false;">PDB: 3SN6</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i29"><a href="/doi/suppl/10.1021/jm5019274">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04212"></div></div></div></div></div><hr /></hr><p class="last">Reaction conditions for the preparation of <b>12a</b>–<b>12n</b> and <b>15a</b>–<b>15d</b> intermediates, characterization data for all other compounds, pharmacological profiling data of compounds (+)-<b>16b</b> and (+)-<b>16d</b>, and details of the modeling study. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5019274/suppl_file/jm5019274_si_001.pdf">jm5019274_si_001.pdf (693.8 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5019274&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm5019274%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-4" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5019274" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993bb049c53da0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
